ahpba 2018 finalprogram press 1 · ahpba 2018 annual meeting 47 wednesday, march 7, 2018 12:45pm -...

45AHPBA 2018 ANNUAL MEETING

AGENDA

AHPBA_2018_FinalProgram.indd 45 2/22/18 9:13 PM

46 MARCH 7 – 11, 2018 | MIAMI BEACH, FLORIDA

7:30am - 5:00pm

Ultrasound & Advanced Technology Course

Cowrie Foyer, Cowrie 1/2

7:30am - 8:00pm

Ultrasound & Advanced Technology Course Registration and Breakfast

8:00am - 9:20am

Welcome and Course Overview

Ellen J. Hagopian MD | Hackensack Meridian

US Principles & Instrumentation

Ellen J. Hagopian MD | Hackensack Meridian

US Scanning Techniques: TAUS, IOUS & LAP

Eren Berber MD | Cleveland Clinic Foundation

9:20am - 9:30am

Ultrasound Course Break

9:30am - 12:00pm

Liver US: Normal Anatomy and Pathologic Findings

Reid Adams MD | University of Virginia School of Medicine

Pancreatobiliary US: Normal Anatomy and Pathology

Nicholas Zyromski MD | Indiana University School of Medicine

Introduction to Hands On Sessions

Ellen Hagopian | Hackensack Meridian

10:50am – 11:00am


HPB Anatomy and Techniques: TAUS

Thomas A. Aloia | The University of Texas, MD Anderson Cancer Center



T. Clark Gamblin MD | Medical College of Wisconsin

Chet Hammill MD | Washington University

D. Rohan Jeyarajah MD | Trinity Care Surgical

Martin Palavecino MD | Hospital Italiano de Buenos Aires


12:00pm - 12:45pm

Ultrasound & Advanced Technology Course Luncheon

WEDNESDAY, MARCH 7, 2018

AG E N DA




12:45pm - 2:15pm

Techniques in Ultrasound Guidance: TAUS, IOUS & LAP

David Iannitti MD | Carolinas HealthCare System

Methods of Tumor Ablation in HPB Surgery

Robert CG Martin MD, PhD | University of Louisville

US Coding, Billing for the HPB Surgeon


Getting Started

Ellen Hagopian | Hackensack Meridian

2:15pm - 2:30pm


Cowrie Foyer

2:30pm - 5:00pm

Scanning Methods and Ultrasound Guidance: IOUS & LAP

Hands On Lab Using Inanimate and Phantom Models

Thomas A. Aloia MD | The University of Texas, MD Anderson Cancer Center



T. Clark Gamblin MD | Medical College of Wisconsin

Chet Hammill MD | Washington University

W. Scott Helton MD | Virginia Mason Medical Center

David Iannitti MD | Carolinas HealthCare System


Martin Palavecino MD | Hospital Italiano de Buenos Aires

Dennis Vrochides MD | Carolinas HealthCare System


12:30pm - 1:30pm

Surgical Innovation Committee Meeting

Hospitality room 432

12:30pm - 1:30pm

Professional Development Committee Meeting

Periwinkle

1:30pm - 2:30pm

Clinical Trials Committee Meeting


AG E N DA



1:30pm - 2:30pm

Conflict of Interest (COI) Committee Meeting


1:30pm - 2:30pm

AHPBF Board Meeting

Periwinkle

2:30pm - 3:30pm

Finance Committee Meeting


2:30pm - 3:30pm

Publications Committee Meeting

Periwinkle

3:00pm - 4:30pm

Education & Training Committee Meeting

Poinciana 3/4

3:30pm - 4:30pm

Program Committee Meeting

Poinciana 1/2

4:30pm - 6:30pm

HPB Program Directors Committee Meeting

Americana 3

4:30pm - 5:30pm

Research Committee Meeting

Poinciana 1/2

5:30pm - 6:30pm

Membership Committee Meeting

Poinciana 3/4

5:30pm - 6:30pm

International Relations Committee Meeting

Poinciana 1/2


AG E N DA



6:00pm - 8:00pm

Registration Open

Rotunda East

6:00pm - 9:00pm

Ultrasound Course Fellows Practicum

Cowrie 1

6:30pm - 9:30pm

Executive Council Meeting

Poinciana 1/2


AG E N DA



6:00am - 9:00am

Ultrasound Course Fellows Practicum

Cowrie 1

7:00am - 6:30pm

Registration Open

Rotunda East

8:00am - 4:30pm

Pre Congress Symposium | HPB Across the Spectrum of Care

Americana 1/2

Moderator: Charles M. Vollmer MD | University of Pennsylvania

8:00am-10:15am

HPB Across the Spectrum of Care | Selecting the Right Patient

Moderators: Herbert J. Zeh MD | University of Pittsburgh Medical Center;

Javier C. Lendoire MD, PhD | Hospital Dr C Argerich

KEYNOTE SPEAKER: Prehab

Richard M. Charnley MD | Freeman Hospital

Bilobar Colorectal Mets: When to Operate?

Rene Adam MD | Paul Brousse Hospital

Cirrhosis and Surgery

Juan Francisco Guerra MD | Pontificia Universidad Católica de Chile

Role of Laparoscopy with HPB Cancers Today

Rebekah R. White MD | University of California San Diego

MIS or Open Whipple?

Horacio J. Asbun MD | Mayo Clinic

Salvage or Sucker: Transplanting the High MELD Patient

Julie K. Heimbach MD | Mayo Clinic

10:15am – 10:30am

Morning Beverage Break

Americana Foyer

THURSDAY, MARCH 8, 2018

AG E N DA



10:30am-12:30pm

HPB Across the Spectrum of Care | Intraop Approaches for Success

Moderators: Carlos Chan MD | National Institute of Medical Sciences;

Sharon Weber, MD | University of Wisconsin

KEYNOTE SPEAKER: Coaching in the OR - Wait A Minute, Slow Down

Carol-anne Moulton MD | University Health Network, University of Toronto

Averting Biliary Leaks

Thomas Aloia MD | MD Anderson Cancer Center

Preventing Pancreatic Leaks

Charles M. Vollmer MD | University of Pennsylvania

Avoiding Blood Loss

Elijah Dixon MD | University of Calgary

Handing Over the Reigns

Paul D. Greig MD | University of Toronto

12:30pm – 1:30pm

Lunch Break (on own)

12:30pm - 1:30pm

AHPBA New Members Lunch with Leadership (by invite only)

Poinciana 3/4

1:30pm-4:30pm

HPB Across the Spectrum of Care | HPB Surgery: It’s Complicated

Moderators: Mariano Gimenez MD | University of Buenos Aires;

Mark P. Callery MD | Harvard Medical School

KEYNOTE SPEAKER: Classification of Complications and Benchmarking

Pierre-Alain Clavien MD PhD | University Hospital Zurich

Dealing with a Bile Duct Injury

Miguel Angel Mercado MD | Instituto Nacional de Ciencias Medicas

Y Nutricion Salvador Zubiran

Post-Op Hemorrhage

Major Lee MD PhD | Univeresity of Pennsylvania

Vascular Complications After a Liver Transplant

Satish N. Nadig MD, PhD | Medical University of South Carolina

Managing Pancreatic Leaks

Giuseppe Malleo MD, PhD | The Pancreas Institute, University of Verona

Dealing with Living Donor Death

Charles Miller MD | Cleveland Clinic


AG E N DA



3:00pm - 4:00pm

Ultrasound Subcommittee Meeting

Cowrie 2

4:30pm – 5:30pm

HPB Collaborative Meeting

Poinciana 1/2

5:30pm - 7:00pm

AHPBA Welcome Reception

Americana 4

5:30pm - 7:30pm

Bernard Langer Fellows Symposium

Americana 1/2

Moderators: M.B. Majella Doyle, MD, MBA | Washington University School of

Medicine; Blaire Anderson, MD | Washington University School of Medicine;

Robert Simon, MD | Cleveland Clinic Foundation

Honorary Welcome

Bernard Langer, MD | Toronto General Hospital

Best Practices for Securing a Job and Transitioning into Practice


How to Position Yourself for Leadership

Elijah Dixon MD | University of Calgary

Training in MIS HPB

Erin H. Baker MD | Carolinas Medical Center

How to Become a Surgical Scientist

Ryan C. Fields MD | Washington University School of Medicine

How to Assure Patients You are Capable

Sean P. Cleary MD | Mayo Clinic

Panelists: HPB Training – A Tripartite Perspective

Houssam G. Osman MD | Methodist Richardson Medical Center

Julie H. Hallet MD, MSc | Sunnybrook Health Sciences Centre,

University of Toronto

Kendra D. Conzen, MD | University of Colorado School of Medicine

9:30pm

Cocktails with AHPBA Leadership

Bar Collins


AG E N DA



6:15am - 7:15am

AHPBF Fund Run

Check-in at Spa Front Desk

7:00am - 6:00pm

Registration Open

Rotunda East

7:00am - 8:00am

Continental Breakfast in Exhibit Hall

Americana 4

7:00am - 8:00am

Industry Sponsored Breakfast Symposium - Thank you Aesculap!

Poinciana 1/2

8:00am – 8:30am

Welcome & Opening Session

AHPBA President, Rebecca Minter MD | University of Wisconsin

8:30am - 9:30am

Presidential Plenary

Americana 1/2

Moderator: Rebecca Minter MD | University of Wisconsin

8:30am - 8:45am

1. MINIMALLY INVASIVE VERSUS OPEN DISTAL PANCREATECTOMY

(LEOPARD): MULTICENTER PATIENT-BLINDED RANDOMIZED

CONTROLLED TRIAL

Presenter: Thijs de Rooij MSc | Academic Medical Center

Invited Discussant: Elijah Dixon MD | University of Calgary

8:45am - 9:00am

2. REGIONAL DIFFERENCES IN GALLBLADDER CANCER

PATHOGENESIS: INSIGHTS FROM A COMPARISON OF TUMOR

MUTATIONS

Presenter: Raja Narayan MD, MPH | Memorial Sloan Kettering Cancer Center

Invited Discussant: Henry Pitt MD | Lewis Katz School of Medicine at Temple

University

FRIDAY, MARCH 9, 2018

AG E N DA



9:00am - 9:15am

3. EVALUATION OF HEPATOCELLULAR CARCINOMA CIRCULATING

TUMOR CELLS EXPRESSING PROGRAMMED DEATH-LIGAND 1

Presenter: Paul Winograd MD | David Geffen School of Medicine at UCLA

Invited Discussant: William Jarnagin MD | Memorial Sloan Kettering Cancer

Center

9:15am - 9:30am

4. SURGICAL COMPLICATIONS AFTER RIGHT HEPATECTOMY FOR LIVE

LIVER DONATION. A SINGLE CENTER EXPERIENCE AFTER >500 CASES

Presenter: Andre Gorgen MD | University Health Network, Toronto General

Hospital

Invited Discussant: Will Chapman MD | Washington University

9:30am - 10:30am

Presidential Address

Americana 1/2

Introduction: Charles M. Vollmer MD | University of Pennsylvania

Inclusivity and Diversity - the AHPBA’s Secret Sauce

Rebecca M. Minter MD | University of Wisconsin

10:30am - 11:00am

Morning Beverage Break, Exhibits & ePoster Viewing

Americana 4

11:00am - 12:30pm

AHPBA-SAGES Joint Symposium: Lap Liver Resections

Americana 1/2

Moderators: Nicholas A. O’Rourke MBBS | Royal Brisbane Hospital;

D. Rohan Jeyarajah MD | Methodist Richardson Medical Center

The State of MIS Liver Surgery

David Geller MD | University of Pittsburgh

Review of ILLS Paris Experience

Daniel Cherqui MD, PhD | Paul Brousse Hospital

Updates from EGMLLS 2017 Experience

Horacio J. Asbun MD | Mayo Clinic

MIS Training for Practicing HPB Surgeons and Fellows

Adnan Alseidi MD, EdM | Virginia Mason Medical Center

South American and Western Experience

Paulo Herman MD | University of São Paulo


AG E N DA



11:00am - 12:30pm

Enhanced Recovery After HPB Surgery

Americana 3

Moderators: Sharon Weber MD | University of Wisconsin – Madison; Dionisios

Vrochides, MD, PhD | Carolinas Medical Center

Relationship Between Enhanced Recovery and Value Based Healthcare


Database Management and Compliance

Erin H. Baker MD | Carolinas Medical Center

Lessons Learned on the Way to a Liver Pathway

Alice C. Wei MD | University Health Network, University of Toronto

Predictive Analytics for Pancreas Pathway Development

Jason W. Denbo MD | University of Minnesota

Anesthesia Perspective: GDFT and Regional Blocks

Vijaya Gottumukkala MD | MD Anderson Cancer Center

11:00am - 12:30pm

Oral Presentations 1: Hepatobiliary

Poinciana 1/2

Moderators: Eddie Abdalla MD | Northside Hospital Cancer Institute; Cassio

Virgilio de Oliveira MD | Universidade Federal da Paraíba

11:00am - 11:12am

5. GROWTH SUPPRESSION BY ALTERATION IN KEAP1/NRF2-NOTCH-

STAT3 SIGNALING IN CHOLANGIOCARCINOMA

Presenter: Muthusamy Kunnimalaiyaan PhD | Medical College of Wisconsin

Invited Discussant: Steve Hughes MD | University of Florida

11:12am - 11:24am

6. LONG-TERM OUTCOMES OF PATIENTS WITH INTRADUCTAL

GROWTH SUB-TYPE OF INTRAHEPATIC CHOLANGIOCARCINOMA

Presenter: Fabio Bagante MD | The Ohio State University

Invited Discussant: Fabio Luiz Waechter MD, PhD | Universidade Federal De

Ciências Da Saúde De Porto Alegre

11:24am - 11:36am

7. DOES ADDITIONAL RE-RESECTION OF A POSITIVE PROXIMAL

MARGIN IN HILAR CHOLANGIOCARCINOMA AFFECT SURVIVAL?

MAYO EXPERIENCE

Presenter: Lavanya Yohanathan MD | Mayo Clinic

Invited Discussant: Mike D’Angelica MD | Memorial Sloan Kettering Cancer

Center


AG E N DA



11:36am - 11:48am

8. IS HEPATECTOMY SAFE FOLLOWING YTTRIUM-90 THERAPY?

A MULTI-INSTITUTIONAL INTERNATIONAL EXPERIENCE

Presenter: Laleh Melstrom MD, MS | City of Hope Cancer Center

Invited Discussant: Parsia Vagefi MD | University of Texas, Southwestern

11:48am - 12:00pm

9. LAPAROSCOPIC PARENCHYMA-SPARING LIVER RESECTION FOR

COLORECTAL METASTASES

Presenter: Davit Aghayan MD | Oslo University Hospital Invited Discussant:

Ching-Wei Tzeng MD | University of Texas, MD Anderson Cancer Center

12:00pm - 12:12pm

10. CHEMORADIOTHERAPY FOR POSITIVE HEPATIC MARGIN ON

CHOLANGIOCARCINOMA

Presenter: Teiichi Sugiura MD | Shizuoka Cancer Center Invited Discussant:

Chandrakanth Are MBBS, MBA | University of Nebraska Medical Center

12:12pm - 12:24pm

11. SURVIVAL AFTER RESECTION OF MULTIPLE TUMOR FOCI OF

INTRAHEPATIC CHOLANGIOCARCINOMA

Presenter: Stefan Buettner BSc | The Ohio State University Invited

Discussant: Kimberly Bertens MD, MPH | The Ottawa Hospital

11:00am - 12:30pm

Oral Presentations 2: Pancreas

Poinciana 3/4

Moderators: Michael Kendrick MD | Mayo Clinic Rochester; Rebecca Snyder MD,

MPH | University of South Carolina School of Medicine- Greenville

11:00am - 11:12am

12. THE CONUNDRUM OF <2 CM PANCREATIC NEUROENDOCRINE

TUMORS: A PREOPERATIVE RISK SCORE TO PREDICT LYMPH NODE

METASTASES AND GUIDE SURGICAL MANAGEMENT

Presenter: Alexandra Lopez-Aguiar MD | Emory University

Invited Discussant: Yumon Fong MD | City of Hope

11:12am - 11:24am

13. EVALUATION OF THE SAFETY AND EFFICACY OF STING AGONISTS

FOR DOWNSTAGING AND MARGIN ACCENTUATION STRATEGIES IN A

MURINE MODEL OF LOCALLY ADVANCED PANCREATIC CANCER

Presenter: Ephraim Tang MD, MSc | Providence Cancer Center

Invited Discussant: Rebecca Snyder MD, MPH | University of South Carolina

School of Medicine-Greenville


AG E N DA



11:24am - 11:36am

14. MONITORING GASTRIC MYOELECTRIC AFTER

PANCREATICODUODENECTOMY FOR DIET “READINESS”

Presenter: Brendan Visser MD | Stanford University

Invited Discussant: Jin He MD, PhD | Johns Hopkins University School of

Medicine

11:36am - 11:48am

15. DECODING GRADE B PANCREATIC FISTULA: A CLINICAL AND

ECONOMICAL ANALYSIS AND SUB-CLASSIFICATION PROPOSAL

Presenter: Giuseppe Malleo MD | University of Pennsylvania

Invited Discussant: Kamran Idrees MD, MSCI, MMHC | Vanderbilt University

Medical Center

11:48am - 12:00pm

16. ENHANCEMENT OF ANTI-TUMOR IMMUNITY AND SURVIVAL

PROLONGATION BY NEOADJUVANT FOLINIC ACID 5-FU, OXALIPLATIN

AND IRINOTECAN (FOLFIRINOX) IN PANCREATIC DUCTAL

ADENOCARCINOMA PATIENTS

Presenter: Lei Cai MD, PhD | Massachusetts General Hospital, Harvard

Medical School

Invited Discussant: George Poultsides MD | Stanford University

12:00pm - 12:12pm

17. QUALITY IMPROVEMENT FOR PANCREATODUODENECTOMY

THROUGH THE DEVELOPMENT AND INTEGRATION OF PROCEDURE-

SPECIFIC RISK ASSESSMENT

Presenter: Brett Ecker MD | University of Pennsylvania

Invited Discussant: Stephen Behrman MD | University of Tennessee Health

Science Center

12:12pm - 12:24pm

18. RADIOLOGICAL FACTORS ASSOCIATED WITH MISSTAGING OF

PANCREATIC DUCTAL ADENOCARCINOMA

Presenter: Ammar Javed MD | Johns Hopkins University School of Medicine

Invited Discussant: Courtney Scaife MD | Huntsman Cancer Institute,

University of Utah


AG E N DA



11:00am - 12:30pm

Oral Presentations 3: Transplant

Cowrie 1/2

Moderators: Anand Annamalai MD | St.Vincents Medical Center; Steven Hanish

MD | University of Maryland

11:00am - 11:12am

19. RISK OF TRANSPLANT WAITLIST PROGRESSION IN

HEPATOCELLULAR CARCINOMA USING BIOMARKERS OF

TUMOR IMMUNE TOLERANCE PRIOR TO TRANSARTERIAL

CHEMOEMBOLIZATION

Presenter: Paul Thevenot PhD | Ochsner Health System

Invited Discussant: Stephen Gray MD | University of Alabama at Birmingham

11:12am - 11:24am

20. HALTHCC AS A NOVEL TUMOR RESPONSE METRIC IN PATIENTS

WITH HEPATOCELLULAR CARCINOMA UNDERGOING LOCOREGIONAL

THERAPY WHILE AWAITING LIVER TRANSPLANTATION

Presenter: Kazunari Sasaki MD | Cleveland Clinic Foundation

Invited Discussant: Karim Halazun MD | Weill Cornell Medicine

11:24am - 11:36am

21. OUTCOMES OF TRANSPLANTATION FOR BIPHENOTYPIC LIVER

TUMORS ARE SIMILAR TO OUTCOMES OF TRANSPLANTATION FOR

HEPATOCELLULAR CARCINOMA

Presenter: Leigh Anne Dageforde MD, MPH | Washington University

Invited Discussant: Vijay Vij MBBS,MS, MRCS | Fortis Hospitals

11:36am - 11:48am

22. IMPACT OF SIDE-TO-SIDE CAVOCAVOSTOMY VERSUS

TRADITIONAL PIGGYBACK IMPLANTATION IN LIVER TRANSPLANT

Presenter: Vikrom Dhar MD | University of Cincinnati

Invited Discussant: John Renz MD, PhD | University of Chicago

11:48am - 12:00pm

23. REDUCING READMISSIONS AFTER LIVER TRANSPLANTATION

Presenter: David Levi MD | Carolinas HealthCare System

Invited Discussant: Chris Sonnenday MD, MHS | University of Michigan


AG E N DA



12:00pm - 12:12pm

24. UNDERSTANDING FIBRINOLYSIS SHUTDOWN IN LIVER

TRANSPLANTATION


Invited Discussant: Kristopher Croome MD | Mayo Clinic Florida

12:12pm - 12:24pm

25. EFFECTS OF SEVOFLURANE METABOLITE HEXAFLUORO-2-

PROPANOL PRECONDITIONING IN EXPERIMENTAL LIVER ISCHEMIA

REPERFUSION INJURY

Presenter: Joel Rocha Filho MD, PhD | Hospital das Clinicas of University

of Sao Paulo

Invited Discussant: Charles Rosen MD | Mayo Clinic

12:00pm – 1:00pm

Industry Lunch Symposium - Thank you Medtronic!

Poinciana 3/4

12:30pm - 1:00pm

Lunch in Exhibit Hall

Americana 4

12:30pm - 1:30pm

Advance Practice Provider Committee Meeting

Cowrie 2

1:00pm - 2:30pm

Vascular Resections in HPB Cancer - When, Where, How?

Americana 1/2

Moderators: Carlos U. Corvera MD | UCSF; Oscar C. Imventarza MD | Hospital

Argerich- Hospital Garrahan

Extended Resections in Pancreatic Cancer

Jeffrey E. Lee MD | UTMD Anderson Cancer Center

IVC Resection with Hepatectomy

Gabriel E. Gondolesi MD | Fundacion Favaloro

Aggressive HCC Resections with Portal Vein Thrombosis

Jean C. Emond MD | Columbia Univeristy and The New York Presbyterian

Hospital

Hilar Cholangiocarcinoma with Vascular Resections

Christopher J. Sonnenday MD, MHS | University of Michigan


AG E N DA



1:00pm - 2:30pm

Does the Evidence Truly Support Aggressive Surgical or Medical Treatment in

HPB Surgery?

Americana 3

Moderators: Jeffrey B. Matthews MD | University of Chicago;

Jose P. Garbanzo MD | Centro de Enfermedades del Higado

Pancreatic Adenocarcinoma

Steven Gallinger MD | University Health Network, University of Toronto

PNETs

Emily R. Winslow MD, MS | University of Wisconsin

Hilar Cholangiocarcinoma

William R. Jarnagin MD | Memorial Sloan Kettering Cancer Center

HCC

Sean P. Cleary MD | Mayo Clinic

Incidental Gall Bladder Cancer: Radical Resection?

Jean M. Butte MD | Instituto Oncologico Fundacion Arturo Lopez Perez

1:00pm - 2:30pm

Mini Oral Sessions | Monitor 1 Pancreas Cancer

Americana Foyer

Moderator: Kevin Billingsley MD | Oregon Health and Science University

1:00pm - 1:05pm

MO 1. OPERATIVE MANAGEMENT OF LOCALLY ADVANCED

PANCREATIC CANCER: ANALYSIS OF THE NATIONAL CANCER

DATABASE

Presenter: Chad Barnes MD | Medical College of Wisconsin

1:05pm - 1:10pm

MO 2. ALL TALK AND NO ACTION: A REVIEW OF THE USE OF

NEOADJUVANT CHEMOTHERAPY FOR PANCREATIC CANCER IN THE

SURVEILLANCE, EPIDEMIOLOGY, AND END RESULTS PROGRAM

Presenter: Erin Gilbert MD | Oregon Health and Sciences University

1:10pm - 1:15pm

MO 3. BILIARY MICROBIOME IN PANCREATIC CANCER: ALTERATIONS

WITH NEOADJUVANT THERAPY

Presenter: Neha Goel MD | Fox Chase Cancer Center


AG E N DA



1:15pm - 1:20pm

MO 4. EXPLORATION OF IRREVERSIBLE ELECTROPORATION INDUCED

APOPTOTIC PATHWAYS AND MECHANISMS IN PANCREATIC

ADENOCARCINOMA CELLS

Presenter: Christopher McNicoll MD, MPH, MS | University of Las Vegas

Nevada School of Medicine

1:20pm - 1:25pm

MO 5. PREDICTORS OF RECURRENCE IN PATIENTS WITH SOLID

PSEUDOPAPILLARY NEOPLASMS OF THE PANCREAS: A SYSTEMATIC

REVIEW AND META-ANALYSIS OF 2579 PATIENTS

Presenter: NATESH YEPURI MBBS | Suny Upstate Medical University

1:25pm - 1:30pm

MO 6. HIGH VOLUME PANCREATICODUODENECTOMY PERFORMED

AT A COMMUNITY CANCER CENTER

Presenter: Arvind Sabesan MD | Helen F Graham Cancer Center & Research

Institute

1:30pm - 1:35pm

MO 7. IMPROVED OVERALL SURVIVAL IN PATIENTS WITH LOCALLY

ADVANCED PANCREATIC CANCER UNDERGOING NEOADJUVANT

THERAPY AND IRREVERSIBLE ELECTROPORATION

Presenter: M. Farzan Rashid BS | Columbia University

1:35pm - 1:40pm

MO 8. RECURRENT OR METACHRONOUS ADENOCARCINOMA OF THE

PANCREATIC REMNANT: LONG-TERM SURVIVAL AFTER COMPLETION

PANCREATECTOMY

Presenter: Thuy Tran MD | Stanford University

1:40pm - 1:45pm

MO 9. THE ROLE OF PRETREATMENT NEUTROPHIL/LYMPHOCYTE

RATIO IN PREDICTING SURVIVAL IN PANCREATIC CANCER PATIENTS

BASED ON NEOADJUVANT CHEMOTHERAPY PATHOLOGICAL

RESPONSE.

Presenter: Basem Azab MD | University of Miami Miller School of Medicine


AG E N DA



1:45pm - 1:50pm

MO 10. EVALUATING A SINGLE NEEDLE HIGH-FREQUENCY

IRREVERSIBLE ELECTROPORATION (H-FIRE) PROBE FOR PANCREATIC

ABLATION IN VIVO.

Presenter: Iain McKillop PhD | Carolinas HealthCare System

1:50pm - 1:55pm

MO 11. A MULTI-INSTITUTIONAL ANALYSIS OF FACTORS AFFECTING

SURVIVAL FOR LEFT-SIDED PANCREATIC ADENOCARCINOMA

Presenter: Farzad Alemi MD | Virginia Mason Medical Center

1:55pm - 2:00pm

MO 12. IMPACT OF TUMOR LOCATION ON RESECTABILITY AND

SURVIVAL FOR PANCREATIC DUCTAL ADENOCARCINOMA


2:00pm - 2:05pm

MO 13. THE CLINICAL IMPACT OF LEFT GASTRIC ARTERY

RECONSTRUCTION/PRESERVATION DURING DISTAL

PANCREATECTOMY WITH CELIAC AXIS RESECTION FOR PANCREATIC

BODY CANCER

Presenter: Atsushi Oba MD, PhD | Cancer Institute Hospital, Japanese

Foundation for Cancer Research

2:05pm - 2:10pm

MO 14. CHEMOTHERAPY VS CHEMORADIATION AS

PREOPERATIVE THERAPY FOR RESECTABLE PANCREATIC DUCTAL

ADENOCARCINOMA: A PROPENSITY SCORE ADJUSTED ANALYSIS

Presenter: Jordan Cloyd MD | The University of Texas MD Anderson Cancer

Center

2:10pm - 2:15pm

MO 15. DOES NEOADJUVANT THERAPY AFFECT PERIOPERATIVE

OUTCOMES IN SARCOPENIC PATIENTS WITH PANCREATIC

ADENOCARCINOMA?

Presenter: Dylan Kahler BA | University of Pittsburgh Medical Center

2:15pm - 2:20pm

MO 16. PREDICTING RE-ADMISSION IN SUBTOTAL PANCREATECTOMY

PATIENTS

Presenter: Michelle Huyser MD | Kaiser Permanente, Oakland Medical

Center


AG E N DA



2:20pm - 2:25pm

MO 17. PANCREATICODUODENECTOMY AND VEIN RESECTION

WITHOUT RECONSTRUCTION FOR LOCALLY ADVANCED PANCREATIC

CANCER: A CASE SERIES

Presenter: Bradley Reames MD, MS | Johns Hopkins University School of

Medicine

2:25pm - 2:30pm

MO 18. IMPACT OF PERIOPERATIVE BLOOD TRANSFUSIONS ON

SURVIVAL IN PATIENTS WITH BORDERLINE RESECTABLE PANCREATIC

ADENOCARCINOMA AFTER NEOADJUVANT THERAPY

Presenter: Rebecca Snyder MD, MPH | The University of Texas MD Anderson

Cancer Center

1:00pm - 2:30pm

Mini Oral Sessions | Monitor 2 Pancreas

Americana Foyer

Moderator: Attila Nakeeb MD | Indiana University

1:00pm - 1:05pm

MO 19. INTERNATIONAL VALIDATION OF THE UPDATED

INTERNATIONAL STUDY GROUP OF PANCREATIC SURGERY

DEFINITION OF POSTOPERATIVE PANCREATIC FISTULA AFTER DISTAL

PANCREATECTOMY

Presenter: Jony van Hilst MD | Academic Medical Center

1:05pm - 1:10pm

MO 20. PANCREATIC AND BILIARY LEAKS IN FRAIL. SAME INCIDENCE,

GRAVE IMPACT

Presenter: Ioannis Konstantinidis MD | City of Hope Cancer Center

1:10pm - 1:15pm

MO 21. LONG TERM EXOCRINE AND ENDOCRINE FUNCTION AFTER

PANCREATECTOMY

Presenter: Blaire Anderson MD | Washington University

1:15pm - 1:20pm

MO 22. THE TRUE COST OF HIGH VOLUME WHIPPLE PROCEDURES

Presenter: Michael Lopez DO | University of Miami- Palm Beach


AG E N DA



1:20pm - 1:25pm

MO 23. DISTAL SPLENORENAL AND MESOCAVAL SHUNTING AT THE

TIME OF PANCREATECTOMY: AN IMPORTANT ADJUNCT TO THE

OPERATIVE MANAGEMENT OF SELECTED PATIENTS.

Presenter: Mariana Chavez MD | Medical College of Wisconsin

1:25pm - 1:30pm

MO 24. PREOPERATIVE CYTOKINE EXPRESSION IS ASSOCIATED WITH

PERIOPERATIVE OUTCOMES AFTER PANCREATECTOMY

Presenter: Malcolm Hart Squires MD | The Ohio State University

1:30pm - 1:35pm

MO 25. DEFINING THE PRACTICE OF DISTAL PANCREATECTOMY

AROUND THE WORLD

Presenter: Giuseppe Malleo MD | University of Pennsylvania

1:35pm - 1:40pm

MO 26. TRENDS AND SEASONALITY IN BILIARY AND ALCOHOLIC

ACUTE PANCREATITIS INCIDENCE IN THE UNITED STATES

Presenter: Steven Clark Cunningham MD | Saint Agnes Hospital Center

1:40pm - 1:45pm

MO 27. TRANSMEMBRANE MUCIN MUC13 DISTINGUISHES

INTRADUCTAL PAPILLARY MUCINOUS NEOPLASMS FROM NON-

MUCINOUS CYSTS AND IS ASSOCIATED WITH HIGH-RISK LESIONS

Presenter: Zachary Stiles DO | University of Tennessee Health Science

Center

1:45pm - 1:50pm

MO 28. WEEKEND EFFECT IS ASSOCIATED WITH ADVERSE OUTCOMES

IN POSTOPERATIVE READMISSIONS FOLLOWING PANCREATIC

RESECTION

Presenter: Anai Kothari MD, MS | Loyola University Medical Center

1:50pm - 1:55pm

MO 29. BILIARY ANASTOMOTIC STRICTURES AFTER

PANCREATICODUODENECTOMY: AN UNDERAPPRECIATED

COMPLICATION

Presenter: Ammar Javed MD | Johns Hopkins University School of Medicine


AG E N DA



1:55pm - 2:00pm

MO 30. COMPLICATIONS FROM RADICAL ANTEGRADE MODULAR

PANCREATICOSPLENECTOMY MAY BE UNDER-REPORTED IN ACS-

NSQIP

Presenter: Tarin Worrest MD | Oregon Health and Sciences University

2:00pm - 2:05pm

MO 31. ANALYSIS OF 90-DAY READMISSION RATES AND HEALTHCARE

COST IN PANCREATIC SURGERY: WHAT IF BUNDLED PAYMENT

SYSTEMS WERE APPLIED TO PANCREATIC SURGERY?

Presenter: Michael LeCompte MD | Vanderbilt University Medical Center

2:05pm - 2:10pm

MO 32. EVALUATING THE ACS-NSQIP RISK CALCULATOR IN PRIMARY

PANCREATIC NEUROENDOCRINE TUMOR: RESULTS FROM THE UNITED

STATES NEUROENDOCRINE TUMOR STUDY GROUP

Presenter: Eliza Beal MD | The Ohio State University Wexner Medical Center

and James Comprehensive Cancer Center

2:10pm - 2:15pm

MO 33. PRESENCE OF ADDICTION DOES NOT PREDICT

WORSE OUTCOMES WITH RESPECT TO PAIN AFTER TOTAL

PANCREATECTOMY WITH ISLET AUTOTRANSPLANTATION

Presenter: Robert Simon MD | Cleveland Clinic Foundation

2:15pm - 2:20pm

MO 34. THE BENEFICIAL EFFECTS OF MINIMIZING BLOOD LOSS IN

PANCREATODUODENECTOMY

Presenter: Thomas Seykora BA | University of Pennsylvania

2:20pm - 2:25pm

MO 35. AN ANALYSIS OF 6,125 PANCREATICOJEJUNAL

ANASTOMOSES: DOES TECHNIQUE MATTER?

Presenter: Lyonell Kone MD, MHS | University of Illinois at Chicago

2:25pm - 2:30pm

MO 36. MACHINE LEARNING AND PREDICTIVE ANALYTICS PROVIDE

INDIVIDUALIZED RISK PROFILES FOR PATIENTS UNDERGOING

MINIMALLY INVASIVE LEFT PANCREATECTOMY

Presenter: Michael Passeri MD | Carolinas HealthCare System


AG E N DA



1:00pm - 2:30pm

Mini Oral Sessions | Monitor 3 Liver

Americana Foyer

Moderator: David Iannitti MD | Carolinas HealthCare System

1:00pm - 1:05pm

MO 37. WHO NEEDS A DRAIN AFTER MAJOR HEPATECTOMY?

Presenter: Konstantinos Zorbas MD | Lewis Katz School of Medicine at

Temple University Hospital

1:05pm - 1:10pm

MO 38. CTLA-4 BLOCKADE INDUCES INDOLEAMINE

2,3-DIOXYGENASE WHERE TREATMENT WITH 1-METHYL-D-

TRYPTOPHAN DISPLAYS GREATER TREATMENT EFFECT IN TUMORS

WITH HIGH IDO EXPRESSION.

Presenter: Zachary Brown DO | National Institutes of Health

1:10pm - 1:15pm

MO 39. INCREMENTAL COSTS AND OUTCOMES OF HEPATECTOMY

WITH VS WITHOUT RESECTION FOR METASTATIC CANCER

Presenter: Jay Idrees MD | The Ohio State University

1:15pm - 1:20pm

MO 40. SUPERUSERS OF POSTOPERATIVE HEPATOBILIARY CARE:

IDENTIFYING DRIVERS OF EXTREME HEALTHCARE COSTS USING THE

NATIONAL SURGICAL QUALITY IMPROVEMENT PROGRAM

Presenter: Sarah Brownlee BA | Loyola University Medical Center

1:20pm - 1:25pm

MO 41. DOES METABOLIC SYNDROME AFFECT THE SHORT- AND

LONG-TERM OUTCOMES OF PATIENTS UNDERGOING HEPATIC

RESECTION? ANALYSIS OF A SINGLE TERTIARY CENTER DATABASE

Presenter: Mohammed Al-Temimi MD, MPH | Kaiser Permanente, Los

Angeles Medical Center

1:25pm - 1:30pm

MO 42. QUANTITATIVE CT IMAGING FEATURES CORRELATE WITH

COLORECTAL CANCER LIVER METASTASES (CLM) MUTATIONAL

STATUS

Presenter: Rebecca Marcus MD | The University of Texas MD Anderson

Cancer Center


AG E N DA



1:30pm - 1:35pm

MO 43. PRINGLE MANEUVER DURING LIVER RESECTIONS IN THE

UNITED STATES: PATTERNS OF USE AND IMPACT IN OUTCOMES

Presenter: Ali Mokdad MD, MS | University of Texas Southwestern

1:35pm - 1:40pm

MO 44. QUANTINTATIVE RISK ASSESSMENT FOR POST-

HEPATECTOMY LIVER FAILURE: ANALYSIS OF THE 2015 ACS-NSQIP

PROCEDURE-TARGETED HEPATECTOMY DATABASE

Presenter: Yana Puckett MD | Texas Tech University Health Sciences Center

1:40pm - 1:45pm

MO 45. THE LIVER HANGING MANEUVER REVISITED: A CADERVERIC

STUDY OF THE WIDTH OF THE RETRO-HEPATIC AVASCULAR SPACE

Presenter: Atsushi Shimizu MD, PhD | Jichi Medical University

1:45pm - 1:50pm

MO 46. THE USE OF INDOCYANINE GREEN FLUORESCENCE FOR

INTRAOPERATIVE VISUALIZATION OF LIVER TUMORS

Presenter: Eren Berber MD | Cleveland Clinic Foundation

1:50pm - 1:55pm

MO 47. KRAS MUTATIONAL STATUS SURPASSES THE TREATMENT

MODALITY IN PATIENTS WITH COLORECTAL LIVER METASTASES

Presenter: Hideo Takahashi MD | Cleveland Clinic Foundation

1:55pm - 2:00pm

MO 48. LONG TERM ONCOLOGIC OUTCOMES OF ROBOTIC LIVER

RESECTION FOR PRIMARY LIVER CANCERS

Presenter: Sidrah Khan MD | University of Pittsburgh Medical Center

2:00pm - 2:05pm

MO 49. YOUNGER PATIENTS WITH RESECTABLE COLORECTAL LIVER

METASTASES HAVE COMPARABLE SURVIVAL TO OLDER PATIENTS

DESPITE WORSE HISTOPATHOLOGIC FEATURES AND INCREASED RAS

MUTATIONS

Presenter: Claire Goumard MD | The University of Texas MD Anderson

Cancer Center


AG E N DA



2:05pm - 2:10pm

MO 50. BENEFITS OF HAND-ASSISTED LAPAROSCOPIC HEPATECTOMY

Presenter: Luis Mercado MD | Hospital Universitario Fundación Favaloro

2:10pm - 2:15pm

MO 51. UNIQUE TECHNICAL COMPLEXITIES AND EFFICACY OF ERCP

AFTER IRREVERSIBLE ELECTROPORATION FOR LOCALLY ADVANCED

PANCREATIC CANCER

Presenter: Neal Bhutiani MD | University of Louisville School of Medicine

2:15pm - 2:20pm

MO 53. PROGNOSTIC SIGNIFICANCE OF PRIMARY TUMOR SIDEDNESS

IN PATIENTS UNDERGOING LIVER RESECTION FOR METASTATIC

COLORECTAL CANCER

Presenter: Jenny Lim MD, MHSc | Duke University Medical Center

2:20pm - 2:25pm

MO 54. TUMOR GRADE SHOULD INFLUENCE THE UTILIZATION OF

PORTAL LYMPHADENECTOMY FOR EARLY STAGE INTRAHEPATIC

CHOLANGIOCARCINOMA

Presenter: Sean Martin DO | National Institutes of Health

1:00pm - 2:45pm

Mini Oral Sessions | Monitor 4 GB/Cholangiocarcinoma/PNET

Americana Foyer

Moderator: T. Clark Gamblin MD, MS, MBA | Medical College of Wisconsin

1:00pm - 1:05pm

MO 55. STAGING GALLBLADDER CANCER WITH LYMPHADENECTOMY:

THE PRACTICAL APPLICATION OF 6 LYMPH NODES

Presenter: Natasha Leigh MD | Icahn School of Medicine at Mount Sinai

1:05pm - 1:10pm

MO 56. IMPROVING OUTCOMES OF CHOLANGIOCARCINOMA: AN

ANALYSIS OF THE SEER DATABASE

Presenter: Aitua Salami MD, MPH | Einstein Healthcare Network

1:10pm - 1:15pm

MO 57. REVISION OF NATIONWIDE PRACTICE PATTERNS IN THE

MANAGEMENT OF T2 GALLBLADDER CARCINOMA

Presenter: Francisco Igor Macedo MD | University of Miami Miller School of

Medicine


AG E N DA



1:15pm - 1:20pm

MO 58. PREOPERATIVE BILIARY STENTING IS ASSOCIATED WITH

INCREASED COMPLICATIONS AFTER LIVER RESECTION FOR

CHOLANGIOCARCINOMA

Presenter: Rajesh Ramanathan MD | University of Pittsburgh Medical Center

1:20pm - 1:25pm

MO 59. SURGERY MAY NOT IMPROVE SURVIVAL FOR LYMPH NODE

POSITIVE INTRAHEPATIC CHOLANGIOCARCINOMA COMPARED TO

CHEMOTHERAPY ALONE

Presenter: Scott Kizy MD | University of Minnesota

1:25pm - 1:30pm

MO 60. R1 RESECTION IN HILAR CHOLANGIOCARCINOMA MIGHT NOT

TRANSLATE TO INFERIOR PATIENT SURVIVAL; AN INTENTION TO

TREAT ANALYSIS


1:30pm - 1:35pm

MO 61. NEOADJUVANT SYSTEMIC THERAPY FOR

CHOLANGIOCARCINOMA : A NSQIP DATABASE ANALYSIS

Presenter: Dominic Sanford MD | Mayo Clinic, Florida

1:35pm - 1:40pm

MO 62. MAJOR COMPLICATIONS FOLLOWING PANCREATECTOMY FOR

SMALL PANCREATIC NEUROENDOCRINE AND CYSTIC NEOPLASMS

LESS THAN 2-CM: AN ARGUMENT FOR SELECTIVE OBSERVATION OR

RESECTION

Presenter: Thuy Tran MD | University of Illinois at Chicago

1:40pm - 1:45pm

MO 63. SAFETY AND EFFICACY OF IRREVERSIBLE ELECTROPORATION

IN THE TREATMENT OF OBSTRUCTIVE JAUNDICE IN LOCALLY

ADVANCED HILAR CHOLANGIOCARCINOMA

Presenter: Emily Martin MEng | University of Louisville School of Medicine

1:45pm - 1:50pm

MO 64. EFFECT OF BLOOD TRANSFUSION ON SURVIVAL FOR

RESECTED PANCREATIC NEUROENDOCRINE TUMORS: ANALYSIS OF

THE U.S. NEUROENDOCRINE STUDY GROUP

Presenter: Paula Marincola Smith MD | Vanderbilt University Medical Center


AG E N DA



1:50pm - 1:55pm

MO 65. ONCOLOGIC OUTCOMES OF PREOPERATIVE THERAPY FOR

DISTAL CHOLANGIOCARCINOMA

Presenter: Jordan Cloyd MD | The University of Texas MD Anderson Cancer

Center

1:55pm - 2:00pm

MO 66. ROLE OF SURGICAL TREATMENT FOR HEPATOLITHIASIS-

ASSOCIATED INTRAHEPATIC CHOLANGIOCARCINOMA: A

RETROSPECTIVE STUDY IN A SINGLE INSTITUTION

Presenter: Weidong Xiao MD, PhD | The First Affiliated Hospital of Nanchang

University

2:00pm - 2:05pm

MO 67. IS PRIMARY SCLEROSING CHOLANGITIS-RELATED

GALLBLADDER CANCER ASSOCIATED WITH WORSE SURVIVAL?

RESULTS FROM THE U.S. EXTRAHEPATIC BILIARY MALIGNANCY

CONSORTIUM

Presenter: Victoria Rendell MD | University of Wisconsin School of Medicine

and Public Health

2:05pm - 2:10pm

MO 68. INCIDENCE OF GALLBLADDER CANCER AND OVERALL

SURVIVAL IN DIFFERENT RACIAL POPULATIONS IN NORTHERN

CALIFORNIA

Presenter: Michelle Huyser MD | Kaiser Permanente, Oakland Medical

Center

2:10pm - 2:15pm

MO 69. IS CYTOREDUCTIVE SURGERY AND HYPERTHERMIC

INTRAPERITONEAL CHEMOTHERAPY INDICATED IN HEPATOBILIARY

MALIGNANCIES?

Presenter: Natasha Leigh MD | Icahn School of Medicine at Mount Sinai

2:15pm - 2:20pm

MO 70. A LITERATURE-BASED TREATMENT ALGORITHM FOR LOW-

GRADE NEUROENDOCRINE LIVER METASTASES

Presenter: Neal Bhutiani MD | University of Louisville School of Medicine

2:20pm - 2:25pm

MO 71. RE-RESECTION IN INCIDENTAL GALLBLADDER CANCER: LYMPH

NODES RETRIEVED IN OPEN VS LAPAROSCOPIC APPROACH

Presenter: Oscar Guevara MD, MSc | Universidad Nacional de Colombia


AG E N DA



2:25pm - 2:30pm

MO 72. THE INTERSECTION OF SURGERY AND BIOENGINEERING:

INNOVATIVE SOLUTIONS FOR CLINICAL PROBLEMS IN PANCREATIC

AND OTHER CANCERS.

Presenter: Matthew Ware PhD | Baylor College of Medicine

2:30pm - 2:35pm

MO 73. REPEAT CHOLECYSTECTOMY FOR THE RETAINED

GALLBLADDER REMNANT: PRESENTATION AND MANAGEMENT

Presenter: Seth Concors MD | University of Pennsylvania

2:35pm - 2:40pm

MO 74. PROGNOSTIC VALUE OF HEPATOCELLULAR CARCINOMA

STAGING SYSTEMS: A COMPARISON

Presenter: Shelby Bergstresser BS | University of Alabama at Birmingham

School of Medicine

2:40pm - 2:45pm

MO 75. MELD SCORE IS AN INDEPENDENT PREDICTOR OF MORTALITY

IN PATIENTS WITH NORMAL LIVER PARENCHYMA AFTER LIVER

RESECTION

Presenter: Victor Zaydfudim MD, MPH | University of Virginia

1:30pm - 2:30pm

Latin American Presidents Committee Meeting

Cowrie 2

2:30pm - 3:30pm

Clinical Trials in Progress: Barriers to Prospective Trials in HPB Surgery

Americana 1/2

Moderators: Daniel E. Abbott MD | University of Wisconsin;

Natalie Coburn MD, MPH | The Odette Cancer Centre

Collaborative Multicenter Trials in HBP Surgery

Michael D’Angelica MD | Memorial Sloan Kettering Cancer Center

Oslo COMET Randomized Trial: Lessons Learned

Asmund A. Fretland MD | Oslo University Hospital

Single Center Prospective Trials: Are They Worth It?

Peter J. Allen MD | Memorial Sloan Kettering Cancer Center

Where Should the Funding Come From and How to Get It?

Charles A. Staley MD | Emory University


AG E N DA



2:30pm - 3:30pm

State of the Art Lecture | Of Math and Medicine

Americana 3

Moderator: Hari Nathan, MD, PhD | University of Michigan

Advancing Surgical Policy and Practice Through Big Data

Dorry Segev MD PhD | Johns Hopkins University

2:30pm - 3:30pm

Basic Translational Science

Poinciana 1/2

Moderators: Ryan C. Fields MD | Washington University School of Medicine;

Vikas Dudeja MD | University of Miami

Personalized Medicine in Biliary Tract Cancers

Jason K. Sicklick MD | University of California, San Diego Moores Cancer Center

Role of CMV in Allograft Chronic Rejection

Susan L. Orloff MD | Oregon Health & Science University

Hypothermic Ex Vivo Liver Perfusion

James V. Guarrera MD | Rutgers New Jersey Medical School

Novel Targets in Pancreas Cancer

William G. Hawkins MD | Washington University in St. Louis

3:30pm - 4:00pm

Afternoon Beverage Break, Exhibit & ePoster Viewing

Americana 4

4:00pm - 5:00pm

Leslie H. Blumgart Historical Lecture

Americana 1/2

Introduction

Katy Morgan MD | Medical University of South Carolina

A Pancreas Odyssey

David B. Adams MD | Medical University of South Carolina


AG E N DA



5:00pm - 6:30pm

Women in Surgery | Navigating the Dual Career Waters

Cowrie 1/2

Moderators: Rebecca M. Minter, MD | University of Wisconsin;

Cristina Ferrone MD | Massachusetts General Hospital

Navigating the Tale of Two Cities

Susan L. Orloff MD | Oregon Health & Science University

The Nonportable Spouse

Rebekah R. White MD | University of California San Diego

HPB Training: A South American Marriage Perspective

Patricia A. Rebolledo MD | Hospital San Borja Arriaran

5:00pm - 6:30pm

State of the Art Symposium | Current Management of Colorectal Liver

Metastases

Americana 3

Moderators: Michael G. House MD | Indiana University School of Medicine;

Felipe J. Coimbra MD | AC Camargo Cancer Center

Resectable Liver Mets - Resect or Chemo First?

Rene Adam MD | Paul Brousse Hospital

Synchronous Rectal Metastasis: Algorithm

Moises Cukier MD | National Cancer Institute - Panama

Understanding Steatohepatitis and How to Tackle It

Yuman Fong MD | City of Hope

Gene Sequencing, Mutations and Prediction Models

Nicholas Vauthey MD | MD Anderson Cancer Center

Current Role of HIPEC with Colorectal Cancer

Kaitlyn J. Kelly MD | UC San Diego


AG E N DA



5:00pm - 6:30pm

Video Session - Pancreas

Americana 1/2

Moderators: Matthew Weiss MD | Johns Hopkins Hospital; Sergio Lopez Torrez

MD, MSc | Hospital Roberto Calderon

5:00pm - 5:12pm

V 1. PANCREATICODUODENECTOMY WITH MESOCAVAL SHUNT FOR

LOCALLY ADVANCED PANCREATIC ADENOCARCINOMA

Presenter: Eve Simoneau MD, PhD | The University of Texas MD Anderson

Cancer Center

5:12pm - 5:24pm

V 2. LAPAROSCOPIC PUESTOW PROCEDURE AFTER OPEN WHIPPLE

FOR PRIMARY PANCREATIC DUCT STONE

Presenter: Armando Rosales MD | Cleveland Clinic Florida

5:24pm - 5:36pm

V 3. ROBOTIC TRANSDUODENAL APPROACH TO A LARGE

PERIAMPULLARY SESSILE TUBULOVILLOUS ADENOMA


5:36pm - 5:48pm

V 4. LAPAROSCOPIC ROUX-EN-Y LONGITUDINAL PANCREATICO-

JEJUNOSTOMY FOR CHRONIC OBSTRUCTION OF THE MAIN

PANCREATIC DUCT

Presenter: Fabio Makdissi MD | University of Sao Paulo

5:48pm - 6:00pm

V 5. PANCREATO-ENTERIC RECONSTRUCTION FOLLOWING ROBOTIC

PANCREATO-DUODENECTOMY. IS ONE TYPE OF RECONSTRUCTION

BETTER THAN THE OTHER?

Presenter: Eduardo Fernandes MD, PhD | University of Illinois at Chicago

6:00pm - 6:12pm

V 6. SUTURE-LESS BINDING PANCREATICOGASTROSTOMY : A VIDEO

DEMOSTRATION

Presenter: Phani Krishna Ravula MS, MRCS, MCh | Pace hospitals

6:12pm - 6:24pm

V 7. Extended hepatectomy with IVC Replacement using Venous Bypass

Presenter: Daniel Cherqui MD | Paul Brousse Hospital - Université Paris Sud


AG E N DA



6:30pm - 7:00pm

Women in Surgery Reception

Cowrie Foyer

6:30pm - 7:30pm

AHPBA Cocktail Reception in Exhibit Hall

Americana Foyer and Americana 4

7:30pm - 10:00pm

AHPBA Congress Banquet

Americana Lawn


AG E N DA



6:30am - 6:00pm

Registration Open

Rotunda East

6:45am - 8:00am

Continental Breakfast in Exhibit Hall

Americana 4

7:00am - 8:00am

Professor Rounds | The Difficult Bile Duct

Cowrie 1/2

Moderators/Speakers:

Jeffrey S. Barkun MD | McGill University Health Centre

Jean C. Emond MD | Columbia University and The New York

Presbyterian Hospital

7:00am - 8:00am

Professor Rounds | Developing a Career in HPB Surgery? Chair’s Perspective

Periwinkle


Lynt B. Johnson MD | Medstar Georgetown University Hospital

David C. Linehan MD | University of Rochester Medical Center

Jennifer F. Tseng MD, MPH | Boston University School of Medicine

7:00am - 8:00am

Professor Rounds | Technical Pearls and Disasters During Whipple Procedure

Poinciana 1/2


Syed A. Ahmad MD | University of Cincinnati

Douglas B. Evans MD | Medical College of Wisconsin

Juan M. Sarmiento MD | Emory University

7:00am - 8:00am

Professor Rounds | Assessing Marginal Livers and How to Transplant Them

Poinciana 3/4


Benjamin Samstein MD | Weill Cornell Medicine

Joe Tector MD, PhD | University of Alabama at Birmingham

Mario Vilatoba MD | Instituto Nacional de Ciencias Medicas y Nutricion

SATURDAY, MARCH 10, 2018

AG E N DA



7:30am - 9:00am

Mini Oral Sessions | Monitor 1 HPB Transplant

Americana Foyer

Moderator: Juan Rocca MD | Montefiore Medical Center

7:30am - 7:35am

MO 76. IMPLEMENTATION OF CLINICALLY MEANINGFUL LAB

PROTOCOL: UTILIZING PREDICTIVE ANALYTICS TO GUIDE QUALITY

IMPROVEMENT INITIATIVES FOR PANCREATICODUODENECTOMY

AND HEPATECTOMY PATIENTS

Presenter: Kendra Tezber BSN, RN | Carolinas HealthCare System

7:35am - 7:40am

MO 77. SAFETY OF INTRAOPERATIVE BLOOD SALVAGE DURING

LIVER TRANSPLANTATION IN PATIENTS WITH HEPATOCELLULAR

CARCINOMA; SYSTEMATIC REVIEW AND META-ANALYSIS

Presenter: Vera Rutten MBBS | Erasmus MC

7:40am - 7:45am

MO 78. HIGHEST OVERALL NEUTROPHIL TO LYMPHOCYTE RATIO

ON WAITING LIST PREDICTS RECURRENCE-FREE SURVIVAL IN LIVER

TRANSPLANTATION FOR HEPATOCELLULAR CARCINOMA

Presenter: John McVey BA | Cleveland Clinic Foundation

7:45am - 7:50am

MO 79. RECOMMENDATIONS OF AN INTERNATIONAL

MULTIDISCIPLINARY COMMITTEE ON STANDARDS FOR REPORTING

OUTCOMES OF TREATING BILIARY INJURIES

Presenter: Steven Strasberg MD, PhD | Washington University

7:50am - 7:55am

MO 80. LONG-TERM OUTCOMES OF CHANGE IN INSURANCE

COVERAGE AFTER LIVER TRANSPLANTATION

Presenter: Clifford Akateh MD | The Ohio State University and Nationwide

Children’s Hospital

7:55am - 8:00am

MO 81. SLEEVE GASTRECTOMY DECREASES THE INCIDENCE OF

METABOLIC SYNDROME IN OBESE POST-LIVER TRANSPLANT

PATIENTS

Presenter: Andrew Jung MD | University of Cincinnati


AG E N DA



8:00am - 8:05am

MO 82. LIVER TRANSPLANTATION BY REFRACTORY’S ASCITES

AND ITS CORRELATION WITH THE PRESENCE OF HEPATOCELLULAR

CARCINOMA

Presenter: Andre Gorgen MD | University of Campinas

8:05am - 8:10am

MO 83. ELEVATED RED CELL DISTRIBUTION WIDTH AND OUTCOMES

IN ADVANCED STAGE HCC AT LIVER TRANSPLANT

Presenter: Jacentha Buggs MD | Tampa General Hospital

8:10am - 8:15am

MO 84. LIVER SIZE MISMATCH IN DECEASED DONOR LIVER

TRANSPLANTATION

Presenter: Jacentha Buggs MD | Tampa General Hospital

8:15am - 8:20am

MO 85. WHEN OBSERVED DOES NOT GO AS EXPECTED: DEVASTATING

TRAJECTORIES IN HEPATOBILIARY SURGERY

Presenter: Lindsay Gil BS, BA | Loyola University Medical Center

8:20am - 8:25am

MO 86. BILIARY COMPLICATIONS AFTER PEDIATRIC LIVER

TRANSPLANTATION

Presenter: Adeel Khan MD, MPH | Washington University

8:25am - 8:30am

MO 87. NATIONWIDE OUTCOMES AFTER SURGERY FOR BENIGN

HEPATIC TUMORS

Presenter: Scott Revell MD | University of Miami Miller School of Medicine

8:30am - 8:35am

MO 88. ASSOCIATION BETWEEN DONOR HYPERNATREMIA AND

LIVER TRANSPLANT GRAFT FUNCTION

Presenter: Carlos Florez-Zorrilla MD | Centro Medico Nacional

8:35am - 8:40am

MO 89. THE EFFECT OF DONOR RACE-MATCHING ON OVERALL

SURVIVAL FOR AFRICAN AMERICAN PATIENTS UNDERGOING LIVER

TRANSPLANTATION FOR HEPATOCELLULAR CARCINOMA

Presenter: Jack Silva BS | Medical College of Wisconsin


AG E N DA



8:40am - 8:45am

MO 90. SURVIVAL AND HCC RECURRENCE AFTER LIVER TRANSPLANT

DUE TO NASH RELATED HCC VS. NON-NASH RELATED HCC

Presenter: Julio Sokolich M.D. | Tampa General Hospital

8:45am - 8:50am

MO 91. INCISIONAL HERNIA AFTER LIVER TRANSPLANTATION

Presenter: Heidy Cos MD | Washington University

8:50am - 8:55am

MO 92. LAPAROSCOPIC FREY PROCEDURE. WHAT ARE THE

POTENTIAL CONTRAINDICATIONS ?

Presenter: Roman Izrailov MD | Moscow Clinical Scientific Centre

8:55am - 9:00am

MO 93. DISTAL PANCREATECTOMY FOR PANCREATITIS: DIVERSE

DISEASE WITH DISMAL OUTCOMES

Presenter: William Lancaster MD | Medical University of South Carolina

7:30am - 9:00am

Mini Oral Sessions | Monitor 2 HCC

Americana Foyer

Moderator: Shawn Pelletier MD | University Of Virginia Health System

7:30am - 7:35am

MO 94. OUTCOMES FOLLOWING TRANSARTERIAL EMBOLIZATION

FOR HEPATOCELLULAR CARCINOMA WITH COMPLETE RADIOLOGIC

RESPONSE

Presenter: Michele Babicky MD | Memorial Sloan Kettering Cancer Center

7:35am - 7:40am

MO 95. A COMPARISON OF PRESENTATION AND OUTCOME IN

PATIENTS WITH HEPATOCELLULAR CANCER FROM NONALCOHOLIC

STEATOHEPATITIS AND VIRAL HEPATITIS ETIOLOGIES

Presenter: Caitlin Hester MD | University of Texas Southwestern

7:40am - 7:45am

MO 96. CONDITIONAL PROBABILITY OF SURVIVAL IN PATIENTS WITH

SPONTANEOUS TUMOR RUPTURE ON HEPATOCELLULAR CARCINOMA

AFTER PARTIAL HEPATECTOMY: A PROPENSITY SCORE MATCHING

ANALYSIS

Presenter: Qian Zhu MD, PhD | Zhongda Hospital


AG E N DA



7:45am - 7:50am

MO 97. OPTIMIZING CANCER CARE FOR HEPATOCELLULAR

CARCINOMA AT A SAFETY-NET HOSPITAL: THE VALUE OF A

MULTIDISCIPLINARY DISEASE MANAGEMENT TEAM

Presenter: Grace Duininck BA | Emory University

7:50am - 7:55am

MO 99. GENDER DIFFERENCES IN HEPATOCELLULAR CANCER:

SHOULD FEMALES WITH NONALCOHOLIC FATTY LIVER DISEASE AND

STEATOHEPATITIS UNDERGO SURVEILLANCE FOR HEPATOCELLULAR

CANCER?

Presenter: Eric Wu BS | John A. Burns School of Medicine, University of

Hawaii at Manoa

7:55am - 8:00am

MO 100. INVESTIGATING THE BREATH METABOLOME AS A

DIAGNOSTIC TOOL FOR HEPATOCELLULAR CARCINOMA IN

CIRRHOTIC PATIENTS

Presenter: Lou-Anne Acevedo-Moreno MD | Cleveland Clinic Foundation

8:00am - 8:05am

MO 101. RISK FACTORS FOR VERY EARLY RECURRENCE OF

HEPATOCELLULAR CARCINOMA: A RETROSPECTIVE REVIEW


8:05am - 8:10am

MO 102. UNRAVELLING THE COMPLEXITY MYTH FOR LAPAROSCOPIC

RIGHT HEPATECTOMY

Presenter: Salila Hashmi MD | Emory University

8:10am - 8:15am

MO 103. SELECTIVE LYMPH NODE SAMPLING IN RESECTABLE

HEPATOCELLULAR CARCINOMA: NATIONAL PRACTICE PATTERNS

AND NODE POSITIVITY RATES

Presenter: Andrew Lee MD, PhD | The University of Texas MD Anderson

Cancer Center

8:15am - 8:20am

MO 104. SOCIOECONOMIC FACTORS INCLUDING RACE INCREASE

ODDS OF LATE STAGE DIAGNOSIS OF HCC

Presenter: Marco Aru MS | University of Mississippi Medical Center


AG E N DA



8:20am - 8:25am

MO 105. OUTCOMES AND PREDICTORS OF MORTALITY AFTER

LIVER RESECTION FOR HEPATOCELLULAR CARCINOMA WITH

MACROVASCULAR INVASION: A COHORT STUDY

Presenter: Andre Gorgen MD | University Health Network, Toronto General

Hospital

8:25am - 8:30am

MO 106. A REAL-WORLD APPLICATION OF YTTRIUM90

TRANSARTERIAL RADIOEMBOLIZATION FOR HEPATOCELLULAR

CARCINOMA

Presenter: Kliment Bozhilov MD | John A. Burns School of Medicine,

University of Hawaii at Manoa

8:30am - 8:35am

MO 107. IMPLICATIONS OF UNPLANNED CONVERSION TO AN

OPEN PROCEDURE DURING LAPAROSCOPIC LIVER RESECTION FOR



Center

8:35am - 8:40am

MO 109. REGIONAL UTILIZATION OF SURGERY AND SURVIVAL IN

PATIENTS WITH EARLY STAGE HEPATOCELLULAR CARCINOMA

Presenter: Grace Lee MD | Massachusetts General Hospital

8:40am - 8:45am

MO 110. PREDICTION OF MICROVASCULAR INVASION OF

HEPATOCELLULAR CARCINOMA IN LIVER TRANSPLANTATION

USING QUANTITATIVE PARAMETERS IN DYNAMIC COMPUTED

TOMOGRAPHY.

Presenter: Elaine Ataide PhD | University of Campinas

8:45am - 8:50am

MO 111. SURGICAL RESECTION OF HEPATOCELLULAR CARCINOMA

IN THE CIRRHOTIC PATIENT: ANATOMIC VERSUS NON-ANATOMIC

RESECTION?

Presenter: Anthony Scholer MD, MBS | Rutgers University


AG E N DA



7:30am - 9:00am

Mini Oral Sessions | Monitor 3 HPB Education Cost

Americana Foyer

Moderator: M.B. Majella Doyle MD, MBA | Washington University

7:30am - 7:35am

MO 112. THE LATIN AMERICAN HPB CONSORTIUM OF

EDUCATION AND RESEARCH (LAHCER): A PILOT SURVEY OF

HEPATOPANCREATOBILIARY TRAINING IN LATIN AMERICA

Presenter: Ismael Dominguez Rosado MD, MSc | Instituto Nacional de

Ciencias Médicas y Nutrición, Hospital Italiano de Buenos Aires, Hospital

General de México, Corporación Médica Monte Sinai, Hospital Das Clnicas

FMUSP, Hospital A Beneficiencia Portugues

7:35am - 7:40am

MO 113. WHAT DO HPB FELLOWS EXPECT OF THEIR TRAINING: A

SURVEY OF INCOMING HPB FELOWS AT THE BEGINNING OF THEIR

FELLOWSHIP.

Presenter: Spyridon Pagkratis MD | Methodist Richardson Medical Center

7:40am - 7:45am

MO 114. IMPLEMENTING QUALITY ASSURANCE FOR PANCREATIC

CANCER WITHIN AN INTEGRATED HEALTH SYSTEM

Presenter: Daniel Solomon MD | Icahn School of Medicine at Mount Sinai

7:45am - 7:50am

MO 115. THE ADHERENCE TO CHOLECYSTECTOMY TIMING

GUIDELINES AND ITS EFFECT ON HEALTHCARE AND PATIENT

CENTERED OUTCOMES

Presenter: Nourah Al-Beeshi | King Saud University

7:50am - 7:55am

MO 116. PATIENT-SPECIFIC PREDICTORS OF FAILURE TO RESCUE

AFTER MAJOR HEPATECTOMY

Presenter: Elizabeth Gleeson MD, MPH | Lewis Katz School of Medicine at

Temple University


AG E N DA



7:55am - 8:00am

MO 117. TAILORED MULTISTAGE MINIMALLY INVASIVE MANAGEMENT

OF RESECTABLE STAGE IV COLORECTAL CANCER OFFERS OPTIMAL

POSTOPERATIVE OUTCOMES AND LONG-TERM SURVIVAL: A

PROPENSITY-SCORE WEIGHTING ANALYSIS

Presenter: Claire Goumard MD | The University of Texas MD Anderson

Cancer Center

8:00am - 8:05am

MO 118. EFFICACY AND LIMITATIONS OF 68-GALLIUM DOTATATE

PET/CT FOR NEUROENDOCRINE TUMORS: CLINICAL EXPERIENCE

FOLLOWING FDA APPROVAL

Presenter: Ryan Griffith MD | Saint Joseph Hospital

8:05am - 8:10am

MO 119. THE BENEFIT OF MINIMALLY INVASIVE

PANCREATICODUODENECTOMY ON ENHANCED RECOVERY

IS RESTRICTED TO PATIENTS WHO AVOID POSTOPERATIVE

COMPLICATIONS: A NSQIP ANALYSIS

Presenter: Dominic Sanford MD, MPHS | Washington University

8:10am - 8:15am

MO 120. DISTAL PANCREATECTOMY WITHOUT INTRAPERITONEAL

DRAINAGE: A COST-EFFECTIVE ALTERNATIVE TO ROUTINE

DRAINAGE.

Presenter: Felipe Maegawa MD, MS | Southern Arizona VA Health Care

System/ University of Arizona

8:15am - 8:20am

MO 121. ELDERLY DISPARITIES IN UTILIZATION AND ACCESS TO

TECHNOLOGY IN AN URBAN HEPATOPANCREATOBILIARY SURGICAL

PRACTICE

Presenter: John Hardaway MD, PhD | Roger Williams Medical Center

8:20am - 8:25am

MO 122. COMPARATIVE OUTCOMES OF EARLY AND

STANDARD DISCHARGE IN PATIENTS UNDERGOING

PANCREATODUODENECTOMY

Presenter: Gautam Sharma MD | Cleveland Clinic Foundation


AG E N DA



8:25am - 8:30am

MO 123. ACADEMIC RANK IN HEPATOPANCREATICOBILIARY

SURGEONS: IDENTIFYING BENCHMARKS

Presenter: Amit Khithani MD | City of Hope Cancer Center

8:30am - 8:35am

MO 124. RISK FACTORS FOR 30 DAY READMISSION RATES AFTER

HEPATECTOMY AND PANCREATECTOMY FOR BENIGN DISEASE, AN

ACS NSQIP DATABASE REVIEW.

Presenter: Cara Lyle MD | West Virginia University

8:35am - 8:40am

MO 125. INTEREST IN CAREER IN HEPATOPANCREATOBILIARY

SURGERY AND DIFFERENCES BY GENDER IN CHILEAN GENERAL

SURGERY RESIDENTS -RESULTS OF A NATIONAL SURVEY

Presenter: Diego Garcia MD | Hospital San Borja Arriaran

8:40am - 8:45am

MO 126. POST-HOC VIDEO REVIEW OF ROBOTIC

PANCREATICODUODENECTOMY TO PREDICT CIRCUMFERENTIAL

MARGIN POSITIVITY IN PANCREATIC ADENOCARCINOMA

Presenter: Brian Boone MD | University of Pittsburgh

8:45am - 8:50am

MO 127. PREDICTION ON SURGICAL OUTCOMES OF

VIDEOLAPAROSCOPIC CHOLECYSTECTOMY IN ELDERLY PATIENTS

USING COMORBIDITY COMBINED SCORE

Presenter: Vitor Carminatti Romano MS | Hospital das Clinicas of University

of Sao Paulo

8:50am - 8:55am

MO 128. OUTCOME OF 164 PATIENTS WITH IATROGENIC BILIARY

STRICTURE SUBMITTED TO SURGICAL REPAIR IN A SPECIALIZED

CENTER

Presenter: Estela Figueira MD, PhD | Hospital das Clinicas of University of

Sao Paulo

8:55am - 9:00am

MO 129. DOES FELLOW LEVEL OF TRAINING IMPACT OUTCOMES

AFTER DECEASED DONOR LIVER TRANSPLANTATION?

Presenter: Sandra Garcia-Aroz MD | Washington University


AG E N DA



7:30am - 9:15am

Mini Oral Sessions | Monitor 4 Pancreas

Americana Foyer

Moderator: Alexander Parikh MD, MPH | University of South Carolina, Greenville

7:30am - 7:35am

MO 130. LAPAROSCOPIC TRANSGASTRIC NECROSECTOMY

REDUCES RE-INTERVENTION AND MORBIDITY COMPARED TO OPEN

NECROSECTOMY

Presenter: Patrick Worth MD | Stanford University

7:35am - 7:40am

MO 131. A SINGLE INSTITUTION’S FIRST 100 ROBOTIC

PANCREATICODUODENECTOMIES: A PRODUCT OF THE INEVITABLE

SHIFT TOWARDS MINIMALLY INVASIVE SURGERY

Presenter: Alexander Rosemurgy MD | Florida Hospital, Tampa

7:40am - 7:45am

MO 132. PANCREATODUODENECTOMY IN THE CIRRHOTIC PATIENT:

PREDICTORS OF OUTCOME.

Presenter: James Butler MD, PhD | Indiana University

7:45am - 7:50am

MO 133. RISK FACTORS FOR DEVELOPING DEEP VENOUS

THROMBOSIS & PULMONARY EMBOLISM IN PATIENTS UNDERGOING

PANCREATICODUODENECTOMY

Presenter: Casey Allen MD | University of Miami Miller School of Medicine

7:50am - 7:55am

MO 134. EXPERIENCE OF 215 TOTALLY LAPAROSCOPIC

PANCREATODUODENECTOMIES

Presenter: Magomet Baychorov MD | Moscow Clinical Scientific Centre

7:55am - 8:00am

MO 135. INITIAL REPORTING OF OVERALL SURVIVAL OF THE AHPBA

PANCREATIC REGISTRY

Presenter: Robert CG Martin MD, PhD | University of Louisville School of

Medicine


AG E N DA



8:00am - 8:05am

MO 136. DOES DRAIN SUCTION INFLUENCE THE INCIDENCE OF

CLINICALLY RELEVANT POSTOPERATIVE PANCREATIC FISTULA

Presenter: Jason Liu MD, MS | Lewis Katz School of Medicine at Temple

University

8:05am - 8:10am

MO 137. LAPAROSCOPIC VERSUS ROBOTIC-ASSISTED LEFT

PANCREATECTOMY FOR ADENOCARCINOMA AT A HIGH VOLUME,

MINIMALLY INVASIVE CENTER

Presenter: William Lyman MD | Carolinas HealthCare System

8:10am - 8:15am

MO 138. OPEN PANCREATIC DÉBRIDEMENT: CONTEMPORARY

OUTCOMES IN CHANGING TIMES

Presenter: Thomas Maatman MD | Indiana University

8:15am - 8:20am

MO 139. COMPLIANCE WITH ERAS PROTOCOLS IMPROVES OVERALL

AND DISEASE FREE SURVIVAL AFTER PANCREATICODUODENECTOMY


8:20am - 8:25am

MO 140. ANTIPLATELET THERAPY AFTER

PANCREATICODUODENECTOMY WITH PORTAL VEIN RESECTION MAY

BE THE OPTIMAL ANTICOAGULANT

Presenter: Amit Sastry MD | Carolinas HealthCare System

8:25am - 8:30am

MO 141. IMPROVED MORTALITY AFTER PANCREATECTOMY IN THE

MODERN ERA

Presenter: Michael Lidsky MD | Memorial Sloan Kettering Cancer Center

8:30am - 8:35am

MO 142. PREOPERATIVE PANCREATIC GLAND RADIODENSITY

PREDICTS LEAKS IN DISTAL PANCREATECTOMY, BUT NOT

PANCREATICODUODENECTOMY.

Presenter: Patrick Worth MD | Oregon Health and Sciences University


AG E N DA



8:35am - 8:40am

MO 143. EARLY VERSUS LATE DRAIN REMOVAL AFTER WHIPPLE

PROCEDURE

Presenter: Konstantinos Zorbas MD | Lewis Katz School of Medicine at

Temple University Hospital

8:40am - 8:45am

MO 144. DIFFERENCES IN THE PATTERN AND TIMING OF

RECURRENCE IN PATIENTS AFTER UPFRONT OR POST-NEOADJUVANT

PANCREATECTOMY FOR PANCREATIC DUCTAL ADENOCARCINOMA

Presenter: Vincent P. Groot MD | Johns Hopkins University School of

Medicine

8:45am - 8:50am

MO 145. PATIENTS OVER AGE 70 AT HIGHER RISK FOR PERIOPERATIVE

COMPLICATIONS AFTER DISTAL PANCREATECTOMY FOR

NEUROENDOCRINE AND CYSTIC NEOPLASMS

Presenter: Rajesh Ramanathan MD | Virginia Commonwealth University

Medical Center

8:50am - 8:55am

MO 146. TRAVEL DISTANCE AFFECTS RATES AND REASONS FOR

READMISSION AFTER PANCREATECTOMY

Presenter: Rachel Simpson MD | Indiana University

8:55am - 9:00am

MO 147. THE LONG-TERM OUTCOMES OF RADICAL

PANCREATOSPLENECTOMY FOR PATIENTS WITH DISTAL PANCREATIC

ADENOCARCINOMA

Presenter: Genki Watanabe MD | Cancer Institute Hospital, Japanese


9:00am - 9:05am

MO 148. DABIGATRAN (PRADAXA) IS SAFE FOR EXTENDED VENOUS

THROMBOEMBOLISM PROPHYLAXIS AFTER PANCREATIC ONCOLOGIC

SURGERY

Presenter: M. Farzan Rashid BS | Columbia University


AG E N DA



9:05am - 9:10am

MO 149. THE IMPACT OF TUMOR DIFFERENTIATION ON

PERIOPERATIVE OUTCOMES AND PATTERNS OF RECURRENCE

FOLLOWING PREOPERATIVE THERAPY FOR RESECTABLE PANCREATIC

ADENOCARCINOMA

Presenter: James Lindberg MD | The University of Texas MD Anderson

Cancer Center

9:10am - 9:15am

MO 150. PREOPERATIVE IMAGING CHARACTERISTICS PREDICT

POOR SURVIVAL AND INADEQUATE RESECTION FOR LEFT-SIDED

PANCREATIC ADENOCARCINOMA: A MULTI-INSTITUTIONAL

ANALYSIS

Presenter: Farzad Alemi MD | Virginia Mason Medical Center

8:00am - 9:00am

State of the Art International Symposium | ALPPS for Cancer

Americana 1/2

Moderators: William C. Chapman MD | Washington University School of

Medicine; Javier C. Lendoire MD, PhD | Hospital Dr C Argerich

Colorectal Metastases

Roberto Hernandez-Alejandro MD | University of Rochester

Transplantation After “Failed” ALPPS

Pierre-Alain Clavien MD PhD | University Hospital Zurich

Laparoscopic Version

Marcel Machado MD | University of Sao Paulo

8:00am - 9:00am

Oral Presentations 4: Pancreas II

Poinciana 1/2

Moderators: Claudemiro Quireze Jr MD, PhD | Federal University of Goiás;

Stephen Behrman MD | University of Tennessee Heath Science Center

8:00am - 8:12am

26. CALCIFICATIONS AND CYSTIC MORPHOLOGY ON PREOPERATIVE

IMAGING PREDICT SURVIVAL AFTER RESECTION OF PANCREATIC

NEUROENDOCRINE TUMORS

Presenter: Eleftherios Makris MD, PhD | Stanford University

Invited Discussant: Sameer Patel MD | University of Cincinnati Medical

Center


AG E N DA



8:12am - 8:24am

27. CAN HIGH-VOLUME ANESTHESIOLOGISTS DECREASE

PERIOPERATIVE COSTS FOR PANCREATIC SURGERY?

Presenter: Abhineet Uppal MD | John Wayne Cancer Institute

Invited Discussant: Federico Aucejo MD | Cleveland Clinic

8:24am - 8:36am

28. TUMOR LOCATION PREDICTS PRESENCE OF HIGH GRADE

DYSPLASIA AND INVASIVE CARCINOMA IN INTRADUCTAL PAPILLARY

MUCINOUS NEOPLASMS OF THE PANCREAS

Presenter: Stephanie Kerlakian BS | University of Cincinnati

Invited Discussant: Melissa Hogg MD, MS | UPMC

8:36am - 8:48am

29. ROBOTIC PANCREATODUODENECTOMY WITH VASCULAR

RESECTION: HOW STEEP IS THE LEARNING CURVE?

Presenter: Joal Beane MD | University of Pittsburgh Medical Center

Invited Discussant: Mike Kendrick MD | Mayo Clinic Rochester

8:48am - 9:00am

30. SELECTIVE PANCREATIC STENTING AND RECTAL INDOMETHACIN

IN HIGH-RISK ERCP PATIENTS RESULTS IN SIGNIFICANT DECREASE IN

POST-ERCP PANCREATITIS

Presenter: Wesley Jones MD | University of South Carolina School of

Medicine, Greenville

Invited Discussant: Alex Rosemurgy MD | University of Central Florida,

Florida Hospital Tampa

8:00am - 9:00am

Oral Presentations 5: Liver

Poinciana 3

Moderators: Sukru H. Emre MD | Yale School of Medicine;

Abhishek Mathur MD | Ochsner Clinic

8:00am - 8:12am

31. IN PATIENTS UNDERGOING HEPATIC RESECTION, IS THE LIVER

SURGERY COMPLEXITY SCORE A BETTER PREDICTOR OF CASE

COMPLEXITY AND POSTOPERATIVE MORBIDITY THAN THE

CONVENTIONAL MAJOR/MINOR CLASSIFICATION?


Angeles Medical Center Invited Discussant: David Levi MD | Carolinas

Medical Center


AG E N DA



8:12am - 8:24am

32. IMPROVED PERFORMANCE WITH MINIMALLY INVASIVE LIVER

RESECTION: A SINGLE CENTER WESTERN EXPERIENCE WITH 1,062

CASES

Presenter: Forat Swaid MD | University of Pittsburgh Medical Center

Invited Discussant: Joseph Buell MD, MBA | Tulane University

8:24am - 8:36am

33. A MULTI-INSTITUTIONAL ANALYSIS OF MINIMALLY INVASIVE

LIVER RESECTIONS

Presenter: Alison Smith MD, PhD | Tulane University School of Medicine;

Carolinas Medical Center; City of Hope

Invited Discussant: Sean Cleary MD, MSC, MPH | Mayo Clinic

8:36am - 8:48am

34. STANDARDIZATION OF OPERATIVE TECHNIQUE IN

LAPAROSCOPIC RIGHT HEPATECTOMY: IMPROVING COST-VALUE

RELATIONSHIP THROUGH VALUE STREAM MAPPING

Presenter: Mohammad Raheel Jajja MD | Emory University

Invited Discussant: Clancy Clark MD | Wake Forest Baptist Health

8:48am - 9:00am

35. MULTIDISCIPLINARY, PERIOPERATIVE CARE BUNDLE

DECREASES SURGICAL SITE INFECTION IN PATIENTS UNDERGOING

SYNCHRONOUS COLORECTAL/LIVER RESECTION

Presenter: Lauren Tufts BA | Memorial Sloan Kettering Cancer Center

Invited Discussant: Susanne Warner MD | City of Hope Comprehensive

Cancer Center

9:00am - 10:00am

Betty & Henry Pitt Quality Oration

Americana 1/2

Introduction

Timothy Pawlik, MD, MPH, PhD | The Ohio State University

Achieving Surgical Quality: Observations from the American College of

Surgeons

Clifford Y. Ko MD, MS, MSHS, FACS, FASCRS | University of California-Los

Angeles/American College of Surgeons

10:00am - 10:30am

Morning Beverage Break, Exhibit & ePoster Viewing

Americana Foyer


AG E N DA



10:30am - 12Noon

ASTS/AHPBA Joint Symposium: Multidisciplinary Management of HCC

Americana 1/2

Moderators: Christopher J. Sonnenday MD, MHS | University of Michigan;

Wellington Andraus MD, PhD | Sao Paulo University School of Medicine

Resect When You Can

Cristina Ferrone MD | Massachusetts General Hospital

Why Resect When You Can Ablate?

David A. Iannitti MD | Carolinas HealthCare System

Effectiveness of Liver Directed Therapy

Riad Salem MD, MBA | Northwestern University

Downstage and Then Transplant

Maria B. Doyle MD, MBA | Washington University School of Medicine

Case Presentations

10:30am - 12:00pm

Locally Advanced Pancreatic Cancer

Americana 3

Moderators: Syed A. Ahmad MD | University of Cincinnati Medical Center; Andre

Montagnini MD | Universidade de Sao Paulo, Brazil

Treatment Sequencing for Borderline and Locally Advanced Disease

Matthew Katz MD | UT MD Anderson Cancer Center

Novel Vascular Reconstruction Techniques

Mark J. Truty MD, MS | Mayo Clinic

Can Systematic Therapy Downstage Patients?

Davendra Sohal, MD | Cleveland Clinic

Role of Radiation for Borderline and Locally Advanced Disease

Joseph M. Herman MD | University of Texas MD Anderson Cancer Center

Role for IRE

Robert Martin MD, PhD | University of Louisville


AG E N DA



10:30am - 12:00pm

Video Session HPB

Cowrie 1/2

Moderators: Karim Halazun MD | Weill Cornell Medicine;

Eduardo Montalvo-Jave MD, PhD | Hospital General de Mexico

10:30am - 10:42am

V 8. LAPAROSCOPIC RESECTION OF CAUDATE LOBE. TECHNICAL

STRATEGIES FOR A DIFFICULT LIVER SEGMENT

Presenter: Marcel Autran Machado MD | University of Sao Paulo

10:42am - 10:54am

V 9. FULLY ROBOTIC LEFT HEPATECTOMY FOR HEPATOCELLULAR

CARCINOMA IN A PATIENT WITH HEPTAITIS B CIRRHOSIS

Presenter: Karim Halazun MD | Weill Cornell Medicine

10:54am - 11:06am

V 10. LAPAROSCOPIC RIGHT HEPATECTOMY FOR COMPLEX BILIARY

INJURY AFTER LAPAROSCOPIC CHOLECYSTECTOMY

Presenter: Marcel Autran Machado MD | University of Sao Paulo

11:06am - 11:18am

V 11. LEFT HEMIHEPATECTOMY WITH THROMBECTOMY

FROM INFERIOR VENA CAVA AND RIGHT ATRIUM UNDER

CARDIOPULMONARY BYPASS IN PATIENT WITH HEPATOCELLULAR

CARCINOMA

Presenter: Ruslan Alikhanov MD, PhD | Moscow Clinical Scientific Center

11:18am - 11:30am

V 12. LAPAROSCOPIC RIGHT CAUDATE LOBE MASS RESECTION

Presenter: Benjamin Farber MD | Montefiore Medical Center/Albert Einstein

College of Medicine

11:30am - 11:42am

V 13. LAPAROSCOPIC EXTENDED POSTERIOR SECTORECTOMY

FOR METASTATIC ADRENOCORTICAL CARCINOMA: A MINIMALLY

INVASIVE APPROACH TO PARENCHYMAL PRESERVATION

Presenter: Michael Lidsky MD | Memorial Sloan Kettering Cancer Center

11:42am - 11:54am

V 14. INTERCOSTAL AND GLISSONIAN PEDICLE APPROACH IN

LAPAROSCOPIC LIVER RESECTION FOR BILOBAR TUMORS

Presenter: Tadahiro Uemura MD, PhD | Alleghey Health Network


AG E N DA



10:30am - 12:00pm

Oral Presentations 6: Large Databases

Poinciana 1/2

Moderators: Flavio Paterno MD, MPH | University of Cincinnati; Tun Jie MD |

University of Arizona

10:30am - 10:42am

36. ANATOMICAL HEPATIC RESECTION VERSUS WEDGE RESECTION

FOR GALLBLADDER CANCER: ANALYSIS OF MULTI-CENTER DATABASE


Angeles Medical Center Invited Discussant: Mariano Gimenez MD, PhD |

University of Buenos Aires

10:42am - 10:54am

37. WOUND PROTECTORS MITIGATE SUPERFICIAL SURGICAL SITE

INFECTIONS AFTER PANCREATODUODENECTOMY

Presenter: Jason Liu MD, MS | Lewis Katz School of Medicine at Temple

University

Invited Discussant: Chad Ball MD, MSC | University of Calgary

10:54am - 11:06am

38. DEFINING A LIVER TRANSPLANT BENEFIT THRESHOLD FOR

MODEL FOR END STAGE LIVER DISEASE

Presenter: Eliza W. Beal MD | The Ohio State University

Invited Discussant: Peter Kim MD | University of British Columbia

11:06am - 11:18am

39. LIFE EXPECTANCY AFTER PANCREATIC CANCER RESECTION,

ACCORDING TO HOSPITAL OPERATIVE MORTALITY

Presenter: Mustafa Raoof MD, MS | City of Hope Cancer Center

Invited Discussant: Shishir Maithel MD | Emory University

11:18am - 11:30am

40. ANALYSIS OF OUTCOME OF OPEN AND MINIMAL INVASIVE

PANCREATICODUODENECTOMY USING NSQIP.

Presenter: Hassan Aziz MD | Banner University Medical Center

Invited Discussant: Sharona Ross MD | Florida Hospital, Tampa

11:30am - 11:42am

41. PANCREATECTOMY AND BODY MASS INDEX: AN INTERNATIONAL

EVALUATION OF CUMULATIVE POSTOPERATIVE COMPLICATIONS

USING THE COMPREHENSIVE COMPLICATIONS INDEX

Presenter: Brendan Lovasik MD | Emory University

Invited Discussant:


AG E N DA



11:42am - 11:54am

42. LOCAL REFERRAL OF PANCREATECTOMY PATIENTS TO IMPROVE

SURGICAL QUALITY

Presenter: Margaret Smith MD | University of Michigan

Invited Discussant: Matthew Katz MD | University of Texas, MD Anderson

Cancer Center

12:00pm - 12:30pm

Industry Lunch Symposium - Thank you BTG

Poinciana 3/4

12:00pm - 12:30pm

Lunch in Exhibit Hall

Americana 4

12:30pm - 2:00pm

Fellows Jeopardy

Americana 1/2

12:30pm - 2:00pm

Optimal Margins in HPB Malignancy

Americana 3

Moderators: David Kooby MD | Emory University; Carlos Chan MD | National

Institute of Medical Sciences

Pancreas Cancer: Margin is Critical

Christopher L. Wolfgang MD, PhD | Johns Hopkins

Pancreas Cancer: Margin Doesn’t Matter

David Kooby MD | Emory University

IPMN: Need a Negative Margin

Giuseppe Malleo MD, PhD | Unit of General and Pancreatic Surgery,

University of Verona Hospital Trust

IPMN: Less is More

Nipun B. Merchant MD | University of Miami Hospital

Colorectal Liver Mets: 1cm is mandatory

Flavio G. Rocha MD | Virginia Mason Medical Center

Colorectal Liver Mets: 1mm is Fine

Juan C. Sabogal MD, MSc | Mederi Hospital and San Ignacio Hospital


AG E N DA



12:30pm - 2:00pm

Fellows Jeopardy

Americana 1/2

Moderator: Shishir K. Maithel MD | Emory University

12:30pm – 2:00pm

Consensus Conference | The Role of Somatostatin Analogues in Pancreas

Surgery

Poinciana 1/2

Moderator: John Mansour MD | University of Texas Southwestern Medical Center

Audience Participation

Ajay Maker MD | University of Illinois at Chicago

Introduction

John Mansour MD | University of Texas Southwestern Medical Center

Delphi Process Methods

Natalie Coburn MD | The Odette Cancer Centre

State of the Literature

Charles St. Hill MD | UNLV School of Medicine

Initial Survey Design

Susanne Warner MD | City of Hope

The Consensus Process

Quan Ly MD | University of Nebraska Medical Center

Final Survey Results and Consensus Statements

Clifford Cho MD | University of Michigan Medical School

Audience Participation

Ajay Maker MD | University of Illinois at Chicago

Discussion

Lessons Learned and Future Plans for AHPBA Consensus Conference

John Mansour MD | University of Texas Southwestern Medical Center


AG E N DA



1:00pm - 5:15pm

APP Symposium

Cowrie 1/2

Moderator: Jenna L. Jeganathan PA-C | Cleveland Clinic; Mary Beth Henry RN,

MS, CS, APNP | University of Wisconsin

1:00pm – 3:00pm

Pancreas Cyst Registry

Lan P. Vu PA-C | UT Southwestern Medical Center

Radiology for the HPB APP

Jennifer A. Flood ANP-NC | Memorial Sloan Kettering Cancer Center

Choledochal Cysts

Tanya Kintz DNP, FNP-BC, HNB-BC, AOCNP | Henry Ford Hospital

The Role of the APP in the Care of Liver Transplant Patients

Lacey Bittel PA-C | University of Cincinnati Medical Center

3:00pm - 3:30pm

Afternoon Beverage Break

Americana Foyer

3:30pm – 5:15pm

DVT Prophylaxis

Caitlin Brown NP | University of Pennsylvania

Quick Shot: GDA Bleeding after IRE Treatment of Locally-Advanced

Pancreatic Cancer

Nathan Ogilvie PA-C | Wake Forest Baptist Medical Center

Quick Shot: Pancreatitis…What Lies Beneath?

Veronica L. Coleman MPAS, PA-C | UT Southwestern Medical Center

Quick Shot: Reducing Cost in Healthcare

Morgan L. Bruno ACNP-BC | UT MD Anderson Cancer Center

Quick Shot: Locally Advanced Pancreatic Cancer and (IRE) Irreversible

Electroporation

Sarah Reed MHS, PA-C | Duke University

Quick Shot: Nurse Navigation: An Important Aspect of Multidisciplinary

Care for Hepatopancreaticobiliary Cancer Patients

Alyssa J. Chapates BSN, RN, OCN | Methodist Richardson Cancer Center

Keynote Address: Improving the Patient Experience

Emily R. Winslow MD, MS | University of Wisconsin


AG E N DA



Panel Discussion:

Role of Co-Management of Patients with APP and Surgeon - Which Model

Works Best?

HCAHPs Scores/Patient’s Experience Scores - Do They Correlate with

Better Outcomes?

Patient Coordination/Negotiating Multidisciplinary Care

Interesting Cases to Underscore Collaborative Practice

Panelists: Ashley H. Seawright DNP, ACNP-BC | University of Mississippi

Medical Center; Cherese Lofton, RN | Cleveland Clinic

Lindsey Manos DHSc, PA-C | Johns Hopkins Hospital; Ann Parker CRNP |

George Washington University Hospital

2:00pm - 3:00pm

Presidential Invited Lecture

Americana 1/2

Introduction

Rebecca M. Minter MD | University of Wisconsin

The Diversity Bonus: How Cognitive and Identity Diversity Improve Outcomes

Scott E. Page | University of Michigan

3:00pm - 3:30pm

Afternoon Beverage Break

Americana Foyer

3:30pm - 5:00pm

Business of HPB Surgery: Why It’s Worth It

Americana 3

Moderators: Bryan M. Clary MD, MBA | UC San Diego; Mark S. Talamonti MD |

NorthShore University HealthSystem

Creation and Revenue of an HPB Unit

Melissa Hogg MD MS | University of Pittsburgh Medical Center

Assessing Value and Compensation for HPB Surgeons

Charles R. Scoggins MD, MBA | University of Louisville

Benefits of a Liver Transplant Program

Christopher D. Anderson MD | University of Mississippi of Medical Center

Building Volume, Growth, and Revenue Through Multidisciplinary Clinics

Richard Schulick MD, MBA | University of Colorado School of Medicine

Is It Worth It? Chair’s Perspective

Keith D. Lillemoe MD | Massachusetts General Hospital


AG E N DA



3:30pm - 5:00pm

Changing Paradigm of Necrotizing Pancreatitis

Americana 1/2

Moderators: Nicholas J. Zyromski MD | Indiana University School of Medicine;

Richard M. Charnley MD | Freeman Hospital

Frame the Issue

Nicholas J. Zyromski MD | Indiana University School of Medicine

GI Perspective

Gregory A. Cote MD, MS | Medical University of South Carolina

Percutaneous Approach / Step Up

Rajesh Gupta MD | Postgraduate Institute of Medical Education and Research

Surgical Approach: Open Necrosectomy

Jessica L. Cioffi MD | University of Florida

Surgical Approach: Minimally Invasive Approaches

Chad G. Ball MD, MSC | University of Calgary

3:30pm - 5:00pm

Oral Presentations 7: Basic Science

Poinciana 1/2

Moderators: Allan Tsung MD | University of Pittsburgh Medical Center; Juan

Sanabria MD, MSc | Marhsall University

3:30pm - 3:42pm

43. CD73 AS A NOVEL IMMUNE TARGET AND BIOMARKER IN

PANCREATIC ADENOCARCINOMA

Presenter: Nouredin Messaoudi MD | Centre hospitalier de l’Université de

Montréal

Invited Discussant: Jordan Cloyd MD | The Ohio State University

3:42pm - 3:54pm

44. COLLAGEN TARGETED MRI ACCURATELY MEASURES THE

DESMOPLASTIC RESPONSE TO FOLFIRINOX TREATMENT IN A MURINE

MODEL OF PANCREATIC CANCER

Presenter: Derek Erstad MD | Massachusetts General Hospital, Harvard

Medical School

Invited Discussant: Williams Hawkins MD | Washington University


AG E N DA



3:54pm - 4:06pm

45. INDUCTION OF PD-L1 EXPRESSION IN PANCREATIC TUMOR

MICROENVIRONMENT BY IFN-Y: RATIONALE FOR PD-L1 THERAPY

COMBINATION WITH IRREVERSIBLE ELECTROPORATION THERAPY

Presenter: Young Hong MD | University of Louisville School of Medicine

Invited Discussant: Ryan Fields MD | Washington University

4:06pm - 4:18pm

46. LOCAL VERSUS CIRCULATING IMMUNE CELL POPULATIONS IN

PANCREATIC DUCTAL ADENOCARCINOMA PATIENTS

Presenter: Michael Gerber MD | University of Florida

Invited Discussant: Motaz Qadan MD, PhD | Massachusetts General

Hospital

4:18pm - 4:30pm

47. CHANGE IN CIRCULATING TUMOR DNA AFTER HEPATIC

RESECTION FOR METASTATIC COLORECTAL CANCER

Presenter: Raja Narayan MD, MPH | Memorial Sloan Kettering Cancer Center

Invited Discussant: Ted Welling MD | NYU Langone Health

4:30pm - 4:42pm

48. NOVEL CELL MEMBRANE CATION TRANSPORTER ASSOCIATED

WITH PLATINUM THERAPY RESISTANCE IN PANCREATIC

ADENOCARCINOMA IDENTIFIED THROUGH CRISPR/CAS9 LOSS-OF-

FUNCTION SCREEN

Presenter: Epameinondas Dogeas MD | University of Texas Southwestern

Invited Discussant: Ajay Maker MD | University of Illinois at Chicago

4:42pm - 4:54pm

49. THE EFFECTS OF P-NAK-TIDE AND SW033299 ON NASH

ASSOCIATED CIRRHOSIS IN THE RODENT.

Presenter: Matthew Schade MSc | Marshall University School of Medicine &

Case Western Reserve University School of Medicine

Invited Discussant: Martin Dib MD | University of Wisconsin, Madison

5:15pm - 6:00pm

AHPBA Business Meeting (Members Only)

Americana 1/2

6:15pm - 6:45pm

Advanced Practice Provider Reception

Americana Foyer


AG E N DA



6:30am - 7:30am

AHPBA Leadership & Chapter Presidents Breakfast Meeting

Crown Conch

7:30am - 8:30am

Continental Breakfast

Americana Foyer - The Rotunda

7:30am - 11:30am

Registration Open

Rotunda East

8:00am - 9:30am

Oral Presentations 8: HPB/Transplant

Americana 1

Moderators: Vinay Kapoor MD | SGPGIMS; T. Mark Earl MD | University of

Mississippi Medical Center

8:00am - 8:12am

50. PERIOPERATIVE BLOOD TRANSFUSIONS FOLLOWING HEPATIC

LOBECTOMY: A NATIONAL ANALYSIS OF ACADEMIC MEDICAL

CENTERS IN THE MODERN ERA


Invited Discussant: Tim Pawlik MD, MPH, PhD | The Ohio State University

Wexner Medical Center

8:12am - 8:24am

51. A GENETIC RISK NOMOGRAM FOR PATIENTS WITH COLORECTAL

LIVER METASTASES: THE CENTRAL ROLE OF BRAF MUTATIONAL

STATUS IN STRATIFYING OUTCOMES

Presenter: Georgios Antonios Margonis MD, PhD | Johns Hopkins University

School of Medicine Invited Discussant: Matthew Porembka MD | University

of Texas Southwestern Medical School

8:24am - 8:36am

52. DOUBLE LIGATION OF PORTAL AND HEPATIC VEINS ACHIEVES

HYPERTROPHY COMPARABLE TO ALPPS - A STUDY IN PIGS

Presenter: Erik Schadde MD | Rush University Medical Center

Invited Discussant: Asmund Fretland MD | Oslo University Hospital

SUNDAY, MARCH 11, 2018

AG E N DA



8:36am - 8:48am

53. OPEN VERSUS LAPAROSCOPIC LIVER RESECTION FOR

COLORECTAL LIVER METASTASES LOCATED IN THE POSTERO-

SUPERIOR SEGMENTS: A SUB-GROUP ALAYSIS FROM THE OSLO-

COMET TRIAL

Presenter: Davit Aghayan MD | Oslo University Hospital

Invited Discussant: Emily Winslow MD | University of Wisconsin

8:48am - 9:00am

54. SERUM FACTOR V AS A PREDICTOR OF GRAFT DYSFUNCTION AND

MORTALITY AFTER LIVER TRANSPLANTATION

Presenter: Andre Gorgen MD | Hospital de Clinicas de Porto Alegre

Invited Discussant: Lucio Pereira MD | Hospital Brasilia

9:00am - 9:12am

55. POSITIVE CYSTIC DUCT STUMP AT INDEX CHOLECYSTECTOMY

IN INCIDENTAL GALLBLADDER CANCER IS A STRONG NEGATIVE

PROGNOSTICATOR EVEN IN PATIENTS WITHOUT RESIDUAL DISEASE

AT ONCOLOGIC RE-RESECTION

Presenter: Eduardo Vega MD | The University of Texas MD Anderson Cancer

Center and Hospital Sotero del Rio

Invited Discussant: Allan Tsung MD | University of Pittsburgh Medical

Center65.

9:12am - 9:24am

56. EVALUATION OF LIVER TRANSPLANT RESULTS WITH “LIVERS

THAT NOBODY WANTS”

Presenter: Emilio Quiñonez MD | Hospital el Cruce

Invited Discussant: Ashish Singhal MD | Fortis Hospital

8:00am - 9:30am

Oral Presentations 9: Pancreas III

Americana 2

Moderators: Susanne Warner MD | City of Hope Comprehensive Cancer Center;

Purvi Parikh MD | Kaiser Permanente

8:00am - 8:12am

57. IMPACT OF RECENT GUIDELINES ON OVERTREATMENT OF

ASYMPTOMATIC PANCREATIC CYSTIC LESIONS

Presenter: Katherine Baugh MD | Baylor College of Medicine

Invited Discussant: Kimberly Dalal MD |Palo Alto Medical Foundation


AG E N DA



8:12am - 8:24am

58. EFFECT OF VESSEL PRESERVATION ON SPLENIC VOLUME

AND FUNCTION IN PATIENTS WITH SPLEEN PERSERVING DISTAL

PANCREATECTOMIES.

Presenter: Lavanya Yohanathan MD | University of Toronto

Invited Discussant: Marcus Tan MBBS | Vanderbilt University Medical Center

8:24am - 8:36am

59. OUTCOMES AFTER PANCREATECTOMY WITH ROUTINE USAGE OF

PASIREOTIDE

Presenter: John Kunstman MD, MHS | Memorial Sloan Kettering Cancer

Center

Invited Discussant: Luke Schoeniger MD, PhD | University of Rochester

8:36am - 8:48am

60. PATHOLOGICAL COMPLETE RESPONSE TO CHEMOTHERAPY IN

PANCREATIC CANCER: FREQUENCY, PREDICTORS AND IMPACT ON

OVERALL SURVIVAL.


Invited Discussant: Adam Yopp MD | University of Texas Southwestern

Medical School

8:48am - 9:00am

61. A PROSPECTIVE STUDY OF PASIREOTIDE IN PATIENTS

UNDERGOING PANCREATICODUODENECTOMY: A PROPENSITY SCORE

MATCHED ANALYSIS

Presenter: Dominic Sanford MD MPHS | Washington University

Invited Discussant: Dan Abbott MD | University of Wisconsin

9:00am - 9:12am

62. DOES PERIOPERATIVE FLUID RESUSCITATION IMPACT

PANCREATIC FISTULA RATES AFTER PANCREATICODUODENECTOMY?

Presenter: Leah Winer MD | University of Cincinnati

Invited Discussant: Charles Vollmer MD | University of Pennsylvania

9:12am - 9:24am

63. THE IMPACT OF FAILURE TO ACHIEVE SYMPTOM CONTROL

AFTER RESECTION OF FUNCTIONAL NEUROENDOCRINE TUMORS:

AN 8-INSTITUTION STUDY FROM THE US NEUROENDOCRINE TUMOR

STUDY GROUP

Presenter: Mohammad Zaidi MD, MS | Emory University

Invited Discussant: Heber Salvador de Castro Ribeiro MD | AC Camargo

Cancer Hospital


AG E N DA



8:00am - 9:30am

Oral Presentations 10: Hepatobiliary II

Americana 3

Moderators: Patricio Polanco MD | University of Texas Southwestern Medical

Center; Henry Randall MD | SSM/Saint Louis University Hospital

8:00am - 8:12am

64. COMPLETION, AND NOT JUST INITIATION, OF INTENDED

ONCOLOGIC THERAPY IS ASSOCIATED WITH IMPROVED SURVIVAL

AFTER PANCREATIC RESECTION FOR CANCER

Presenter: Danielle DePeralta MD | Moffitt Cancer Center

Invited Discussant: Eduardo Montalvo-Jave MD, PhD | Hospital General de

Mexico.

8:12am - 8:24am

65. CLINICAL CRITERIA FOR INTEGRATED MOLECULAR PATHOLOGY

IN IPMN: LESS IS MORE

Presenter: Rachel Simpson MD | Indiana University

Invited Discussant: Danny Yakoub MD, PhD | University of Miami

8:24am - 8:36am

66. NORMAL AND FIBROTIC LIVER PARENCHYMA RESPOND

DIFFERENTLY TO IRREVERSIBLE ELECTROPORATION ABLATION

Presenter: Tammy T. Chang MD, PhD | University of California, San Francisco

Invited Discussant: Tri Nguyen MD, PhD | Piedmont Atlanta Hospital

8:36am - 8:48am

67. A COMPARISON OF MICROWAVE THERMOSPHERE VERSUS

RADIOFREQUENCY THERMAL ABLATION IN THE TREATMENT OF

COLORECTAL LIVER METASTASES

Presenter: Kazunari Sasaki MD | Cleveland Clinic Foundation

Invited Discussant: Rob Martin MD, PhD | University of Louisville

8:48am - 9:00am

68. LOSS OF MUSCLE MASS DURING PREOPERATIVE CHEMOTHERAPY

PREDICTS WORSE RECURRENCE-FREE SURVIVIAL IN PATIENTS WITH

RESECTABLE COLORECTAL LIVER METASTASES

Presenter: Masayuki Okuno MD, PhD | The University of Texas MD

Anderson Cancer Center

Invited Discussant: Julie Hallet MD MSc | Sunnybrook Health Sciences

Centre, University of Toronto


AG E N DA



9:00am - 9:12am

69. ONCOLOGICAL BENEFIT OF COMPLETE METASTASECTOMY FOR

SIMULTANEOUS COLORECTAL LIVER AND LUNG METASTASES

Presenter: Masaru Matsumura MD | University of Tokyo

Invited Discussant: Hiromichi Ito MD | Cancer Institute Hospital, Japanese


9:12am - 9:28am

70. DISPARITIES IN HEPATOPANCREATOBILIARY OPERATIVE

EXPERIENCE AMONG GENERAL SURGERY RESIDENTS: A 27-YEAR

ANALYSIS OF ACGME CASE LOGS

Presenter: R. Cutler Quillin, III MD | Columbia University

Invited Discussant: C. Max Schmidt MD, PhD, MBA | Indiana University

School of Medicine

10:00am - 11:30am

Video Session Pancreas HPB

Americana 3

Moderators: Heber Ribeiro MD | AC Camargo Cancer Hospital; Roger Kim MD |

SIU School of Medicine

10:00am – 10:12am

V 15. LAPAROSCOPIC CENTRAL HEPATECTOMY FOR METASTATIC

COLORECTAL CANCER

Presenter: Ephraim Tang MD, MSc | Providence Cancer Center

10:12am - 10:24am

V 16. LAPAROSCOPIC LEFT EXTENDED HEPATECTOMY FOR


Presenter: Katherine MacCallum MD | Montefiore Medical Center

10:24am - 10:36am

V 17. MULTIVISCERAL ROBOTIC LIVER RESECTIONS. FEASIBLE AND

SAFE

Presenter: Ioannis Konstantinidis MD | City of Hope National Cancer Center

10:36am - 10:48am

V 18. LAPAROSCOPIC RIGHT HEPATECTOMY FOLLOWING RIGHT

PORTAL VEIN EMBOLIZATION FOR HEPATOCELLULAR CARCINOMA

Presenter: Katherine MacCallum MD | Montefiore Medical Center


AG E N DA



10:48am - 11:00am

V 19. ROBOTIC CHOLEDOCODUODENOSTOMY

Presenter: Iswanto Sucandy MD | Florida Hospital Tampa

11:00am - 11:12am

V 20. ROBOT-ASSISTED INTRA/EXTRA/BILE DUCT EXPLORATION IN A

SICKLE CELL DISEASE PATIENT WITH BILIARY OBSTRUCTION

Presenter: Gregory Grimberg MD | Rutgers University

11:12am - 11:24am

V 21. LAPAROSCOPIC BEGER PROCEDURE

Presenter: Izrailov Roman MD | Moscow Clinical Scientific Center

10:00am - 11:30am

New Paradigms in Academic HPB Surgery

Americana 1

Moderator: Tara S. Kent MD | Beth Israel Deaconess Medical Center, Harvard

Medical School; Courtney L. Scaife MD | University of Utah

Health Services / Outcomes

Jennifer F. Tseng MD, MPH | Boston University School of Medicine

Multi-Institutional Databases

Timothy M. Pawlik MD, MPH, PhD | The Ohio State University Medical Center

Clinical Trials

William E. Fisher MD | Baylor College of Medicine

Innovation

Mariano Gimenez MD | University of Buenos Aires

International Outreach

T. Peter Kingham MD | Memorial Sloan Kettering Cancer Center

Administrative

Charles Wright Pinson MD, MBA | Vanderbilt University Medical Center


AG E N DA



10:00am - 11:30am

International Relations Committee | AHPBA Gone Global

Americana 2

Moderators: Alagappan Anand Annamalai MD | St. Vincent Medical Center;

Frans I. Serpa MD | Hospital Carlos Andrade Marin

Access to HPB Disease Care Worldwide

Gazi B. Zibari MD | Willis-Knighton Health System

Development of International AHPBA Chapters

Hoover Henriquez Cooper MD | Military Hospital Honduras

How to Improve HPB Education Through the Chapters

Oscar A. Guevara MD, MSc | Universidad Nacional de Colombia /

Instituto Nacional de Cancerologia

Challenges in the Interaction Between AHPBA and the Chapters

Javier C. Lendoire MD, PhD | Hospital Dr C Argeric


AG E N DA



ePoster Displays | Monitor 5

P 2. A PREDICTIVE SCORING SYSTEM FOR INSUFFICIENT LIVER

HYPERTROPHY AFTER PREOPERATIVE PORTAL VEIN EMBOLIZATION

Presenter: Nobuyuki Watanabe MD | Shizuoka Cancer Center

P 5. SINGLE INCISION VERSUS THREE PORT LAPAROSCOPIC

CHOLECYSTECTOMY IN SYMPTOMATIC GALLSTONES: A

PROSPECTIVE RANDOMIZED STUDY

Presenter: Mohammed Omar MD | South Valley University, Qena Faculty of

Medicine

P 7. MALNUTRITION ASSOCIATED WITH POSTOPERATIVE

COMPLICATIONS IN PATIENTS UNDERGONE HEPATECTOMY FOR


Presenter: Tzu Hao Huang MD | Chiayi Chang Gung Memorial Hospital

P 9. CIRRHOTIC CARDIOMYOPATHY AND DIASTOLIC DYSFUNCTION

IN LIVER TRANSPLANTATION

Presenter: Nyingi Kemmer MD | Tampa General Hospital

P 12. VIDEO CASE PRESENTATION: UTILITY OF ROBOTICS IN PARTIAL

HEPATECTOMY FOR ISOLATED LIVER METASTASIS

Presenter: Ashraf Elzanie MD | Saint Vincents Medical Center

P 13. VIDEO PRESENTATION: HAND-ASSISTED LAPAROSCOPIC

DISTAL PANCREATECTOMY AND SPLENECTOMY FOR DISCONNECTED

PANCREATIC DUCT SYNDROME

Presenter: Joseph Kim MD | Icahn School of Medicine at Mount Sinai

P 14. PANCREATICODUODENECTOMY WITH COMMON HEPATIC

ARTERY AND PORTAL VEIN RESECTION FOR LOCALLY ADVANCED

PANCREATIC CANCER

Presenter: Hiromichi Ito MD | Cancer Institution Hospital, Japanese


P 15. LAPAROSCOPIC RESECTION OF A COMPLEX SEGMENT III/IVB

LIVER CYST USING ULTRASONIC SURGICAL ASPIRATOR


ePOSTER DISPLAYS BY MONITOR

AG E N DA



P 16. LAPAROSCOPIC RESECTION OF A SEGMENT VIII COLORECTAL

LIVER METASTASIS USING AN ULTRASONIC SURGICAL ASPIRATOR


P 17. RIGHT POSTERIOR SECTIONECTOMY WITH GLISSONIAN

APPROACH: ADVANTAGES OF HAND-ASSISTED LAPAROSCOPIC

TECHNIQUE

Presenter: Fabio Makdissi MD | University of Sao Paulo

P 19. PERI-OPERATIVE RISK FACTORS FOR POST OPERATIVE LIVER

FAILURE AFTER HEPATECTOMY: AN ACS-NSQIP ANALYSIS

Presenter: Travis Mason MD | Virginia Commonwealth University Medical

Center

P 21. ROBOTIC RESECTION OF EXTRAHEPATIC BILE DUCTS WITH LEFT

HEPATECTOMY AND CAUDATE LOBE RESECTION FOR BISMUTH TYPE

II PERI-HILAR CHOLANGIOCARCINOMA

Presenter: Sarah Corn MD | University of Kansas School of Medicine, Wichita

P 23. LAPAROSCOPIC COMPLETION CHOLECYSTECTOMY: AN AUDIT

FROM THE CARIBBEAN CHAPTER OF THE AHPBA

Presenter: Shamir Cawich MD | University of the West Indies

P 25. LAPAROSCOPIC CHOLEDOCHAL CYST EXCISION WITH

CHOLEDOCHODUODENOSTOMY USING NOVEL ARTICULATING

NEEDLE DRIVER

Presenter: Kellie Helin MD | West Virginia University Charleston

P 26. DUCT-PENETRATING METHOD FOR

PANCREATICOJEJUNOSTOMY USING A SUTURE-ASSISTANCE DEVICE:

OUTCOMES OF EARLY CLINICAL STUDY

Presenter: Tomio Ueno MD, PhD | Kawasaki Medical School

P 27. RESIDENT EXPERIENCE IN HEPATOPANCREATOBILIARY SURGERY

AT HIGH-VOLUME CENTERS: SHOULD IT COUNT?

Presenter: Manuel Castillo-Angeles MD, MPH | Beth Israel Deaconess

Medical Center

P 30. ROBOTIC APPROACH TO PANCREATIC RESECTION RE-VISITED

Presenter: Caitlin Takahashi MS | Florida State University, Sarasota Memorial

Hospital


AG E N DA



P 32. OUTCOMES AFTER PANCREATICODUODENECTOMY IN PATIENTS

WITH SARCOPENIA AND/OR OBESITY


P 33. FACTORS ASSOCIATED WITH RETURN TO OPERATING ROOM

FOLLOWING PANCREATIC RESECTION FOR MALIGNANCY

Presenter: Bradley Hall MD | University of Nebraska Medical Center

P 34. COMPARISON OF NEOADJUVANT GEMCITABINE VERSUS

5-FLUOROURACIL OR CAPECITABINE CHEMORADIATION FOR

BORDERLINE RESECTABLE PANCREATIC CANCER

Presenter: June Peng MD | Cleveland Clinic Foundation

P 36. LONG-TERM OUTCOMES OF PERIAMPULLARY

ADENOCARCINOMAS AFTER PANCREATICODUODENECTOMY – A

PERUVIAN MULTI-INSTITUTIONAL STUDY

Presenter: David Callacondo MD | Hospital Nacional Guillermo Almenara

Irigoyen

P 37. DOES SURGICAL VOLUME TRUMP DISPARITIES IN PREDICTING

OUTCOMES FOLLOWING HEPATOPANCREATICOBILIARY (HPB)

SURGERY?

Presenter: Britney Harris | West Virginia University

P 38. CLINICAL OUTCOMES AFTER MAJOR LIVER RESECTION IN A LOW

VOLUME CENTRE IN THE CARIBBEAN


P 39. LAPAROSCOPIC EXTENDED LYMPHADENECTOMY FOR

INCIDENTAL GALLBLADDER CANCER.

Presenter: Patricia Rebolledo MD | Hospital San Borja Arriaran

P 40. CRITICAL VIEW OF SAFETY IN CHOLECYSTECTOMY IS NOT A

WELL DISSEMINATED CONCEPT. A WEB BASED ANALYSIS


Ciencias Médicas y Nutrición

P 41. SUBCUTANEOUS DRAINAGE TO PREVENT WOUND MORBIDITY

IN PATIENTS UNDERGOING PANCREATICODUODENECTOMIES: A

RETROSPECTIVE STUDY

Presenter: Emilio Alonso MD | Kaiser Permanente, Riverside Medical Center


AG E N DA



P 42. RACIAL DISPARITIES IN SURVIVAL AMONG PATIENTS WITH

RESECTED PANCREATIC ADENOCARCINOMA AND PANCREATIC

NEUROENDOCRINE TUMOR. MIAMI-BASED POPULATION STUDY.


P 44. ARTERIO-VENOUS FISTULA AS A LATE COMPLICATION AFTER

DISTAL PANCREATECTOMY WITH EN BLOC SPLENIC VESSELS

LIGATION: MYTH OR REALITY?

Presenter: John Stauffer MD | Mayo Clinic, Florida

P 46. RESECTION VERSUS OBSERVATION OF SMALL

NONFUNCTIONING PANCREATIC NEUROENODCRINE TUMORS

Presenter: Nir Lubezky MD | Tel-Aviv Medical Center

P 47. THE ANTERIOR SECTOR VENOUS DRAINAGE USING SUPERFICIAL

FEMORAL VEIN GRAFT IN RIGHT LOBE LIVING DONOR LIVER

TRANSPLANTATION

Presenter: Shigeyuki Kawachi MD, PhD | Tokyo Medical University Hachioji

Medical Center

P 48. A SINGLE CENTER EXPERIENCE WITH DIAGNOSTIC

LAPAROSCOPY PRIOR TO PLANNED PANCREATIC RESECTION

Presenter: Jack Silva BS | UC Irvine

P 49. SURGICAL OUTCOMES IN PATIENTS WITH RESECTED

INSULINOMA

Presenter: Georgios Gemenetzis MD | Johns Hopkins University School of

Medicine

P 50. DOES SURGEON VOLUME MITIGATE PREDICTED RISK FOR

PATIENTS UNDERGOING PANCREATODUODENECTOMY?


Center

P 51. IS INTEGER-BASED RISK SCORE TO PREDICT IN-HOSPITAL

MORTALITY FOLLOWING PANCREATECTOMY RELIABLE?

Presenter: SANA BADAR MD | Louisiana State University Health Shreveport


AG E N DA




P 52. TRIGGERS FOR BLOOD TRANSFUSION DURING

PANCREATICODUODENECTOMY: ARE WE FOLLOWING

INSTITUTIONAL GUIDELINES?

Presenter: Daniel Rice BS | University of Cincinnati

P 53. PERIOPERATIVE OUTCOMES OF COMBINED SURGERY OF

PRIMARY COLORECTAL CANCER AND SYNCHRONOUS LIVER

METASTASES

Presenter: Jorge A Gajardo MD | Fundacion Arturo Lopez Perez

P 54. HEPATO-PANCREATO-BILIARY MALIGNANCIES IN PATIENTS

WITH CROHN’S DISEASE: A UNITED STATES POPULATION BASED

STUDY FROM NATIONAL INPATIENT SAMPLE DATABASE (1998-2010)

Presenter: Sachin Patil MD | South Central Regional Medical Cent

P 55. HEPATO-PANCREATO-BILIARY MALIGNANCIES IN PATIENTS

WITH CONNECTIVE TISSUE DISORDERS: A UNITED STATES

POPULATION BASED STUDY FROM NATIONAL INPATIENT SAMPLE

DATABASE (1998-2010)

Presenter: Apostolos Kandilis MD, PhD | Providence Park Hospital/Michigan

State University College of Human Medicine

P 56. IMPLEMENTATION AND EARLY OUTCOMES FOR A SURGEON-

DIRECTED HEPATIC ARTERIAL INFUSION PUMP PROGRAM FOR

COLORECTAL LIVER METASTASES

Presenter: Jeffery Chakedis MD | The Ohio State University

P 57. HEPATIC NEUROENDOCRINE TUMORS WITHOUT AN

IDENTIFIABLE EXTRAHEPATIC PRIMARY

Presenter: Lavanya Yohanathan MD | Mayo Clinic

P 58. TOTAL LAPAROSCOPIC PANCREATODUODENECTOMY WITH

EXTERNALIZED STENT IN A HIGH FISTULA RISK SCENARIO


Ciencias Médicas y Nutrición

P 59. R0 RESECTION IMPROVES DISEASE-FREE SURVIVAL IN PATIENTS

WITH PANCREATIC NEUROENDOCRINE TUMORS INDEPENDENT OF

STAGE AND GRADE OF TUMOR

Presenter: Mazhar Khalil MD | Icahn School of Medicine at Mount Sinai


AG E N DA



P 60. NEO-ADJUVANT CHEOMORADIATION THERAPY FOR

PANCREATIC CANCER IS ASSOCIATED WITH ADVERSE OUTCOME

AFTER PANCREATICODUODECTOMY.

Presenter: Hassan Aziz MD | Banner University Medical Center

P 61. SARCOMATOUS TRANSFORMATION OF HEPATOCELLULAR

CARCINOMA FOLLOWING TREATMENT WITH Y-90

RADIOEMBOLIZATION

Presenter: Connor Wiles BS | Providence Portland Medical Center

P 62. ROBOTIC DUODENAL SURGERY IS A SAFE ALTERNATE TO

LAPAROSCOPIC AND OPEN RESECTION FOR BENIGN AND LOW

GRADE MALIGNANT CONDITIONS NOT AMENABLE TO ENDOSCOPIC

INTERVENTION

Presenter: Adeek Khan MD, MPH | Carolinas HealthCare System

P 63. SURVIVAL ANALYSIS IN PATIENTS WITH GALLBLADER CANCER

IN MEDELLIN-COLOMBIA

Presenter: jaime ramirez MD | IPS Universidad de Antioquia, Clinica Leon XIII

P 64. A MULTI-ORGAN STUDY USING COMPARING MICROWAVE

ABLATION 2450 MHZ SYSTEMS- EQUIVALENCE OR SUPERIORITY

Presenter: Megan Stevenson MD | University of Louisville School of Medicine

P 65. IS ENDOSCOPIC RETROGRADE CHOLANGIO PANCREATOGRAPHY

(ERCP) A RISK FACTOR FOR CONVERSION OF LAPAROSCOPIC

CHOLECYSTECTOMY? - EXPERIENCE OF A TERTIARY CARE

HEPATOBILIARY REFERRAL CENTRE

Presenter: Malith Nandasena MBBS, MD, MRCS | National Hospital of Sri

Lanka

P 66. CHOLEDOCHOPLASTY WITH GALLBLADDER WALL FREE FLAP:

A NOVEL TECHNIQUE FOR MIRIZZI’S SYNDROME AND BILE DUCT

INJURIES IN HIGH RISK PATIENTS

Presenter: Louis Chai MD | Drexel University College of Medicine

P 67. INDOCYANINE GREEN FLUORESCENCE COUNTERSTAINING FOR

ANATOMIC LAPAROSCOPIC PARTIAL SPLENECTOMY

Presenter: Takashi Mizuno MD, PhD | The University of Texas MD Anderson

Cancer Center


AG E N DA



P 68. BMI AND PANCREATIC NECROSIS...DO OBESE PATIENTS DO

WORSE?

Presenter: Stephen Quigley MD | Indiana University

P 69. LONG TERM FOLLOW-UP RESULTS OF SURGICAL MANAGEMENT

OF CHRONIC PANCREATITIS

Presenter: Thiago Costa MD, PhD | Hospital das Clinicas of University of Sao

Paulo

P 71. DO SOLID ORGAN TRANSPLANT RECIPIENTS HAVE A HIGHER

RISK OF HEPATO-PANCREATO-BILIARY MALIGNANCIES? A UNITED

STATES POPULATION BASED STUDY FROM NATIONAL INPATIENT

SAMPLE DATABASE (1998-2010)

Presenter: Apostolos Kandilis MD, PhD | Providence Park Hospital/Michigan

State University College of Human Medicine

P 72. CONVENTIONAL PANCRETICOJEJUNOSTOMY VERSUS SUTURE-

LESS BINDING PANCREATICOGASTROSTOMY- A SINGLE INSTITUTION

SINGLE SURGEON COMPARITIVE STUDY

Presenter: Phani krishna Ravula MS, MRCS, MCh | Pace hospitals

P 73. SURGICAL RESULTS OF MAJOR AND MINOR LAPAROSCOPIC

HEPATECTOMIES

Presenter: Andres Troncoso MD | Pontificia Universidad Católica de Chile

P 74. FEASIBILITY OF LAPAROSCOPIC PARENCHYMAL SPARING

HEPATECTOMIES: A SYSTEMATIC REVIEW

Presenter: Jennifer Kalil MD | Rush University Medical Center

P 75. EFFECT OF INTENSIVE LIFESTYLE INTERVENTIONS ON LIVER

TRANSAMINASES

Presenter: Francisco Ramirez MD | Weimar Institute

P 76. PANCREATICODUODENECTOMY IN PATIENTS WITH ROUX-EN-Y

GASTRIC BYPASS: A MATCHED CASE-CONTROL STUDY

Presenter: John Stauffer MD | Mayo Clinic, Florida

P 77. PATTERNS OF RECURRENCE AND PERI-OPERATIVE PREDICTORS

OF LIVER METASTASIS AFTER PANCREATIC CANCER RESECTION

Presenter: Constantinos Zambirinis MR, MRes | Memorial Sloan Kettering

Cancer Center


AG E N DA



P 78. ORGAN PRESERVING PANCREATECTOMY FOR PANCREATIC

BENIGN OR LOW-GRADE MALIGNANT TUMOR: A REPORT OF 66

CASES IN A SINGLE INSTITUION

Presenter: weidong xiao MD, PhD | The First Affiliated Hospital of Nanchang

University

P 79. LAPAROSCOPIC LIVER RESECTION FOR METASTATIC MELANOMA

Presenter: Davit Aghayan MD | Oslo University Hospital

P 80. LIVER ABSCESS PATHOLOGY AND MANAGEMENT IN WESTERN

SYDNEY

Presenter: Yi Liang MBBS | Westmead Hospital

P 81. MAJOR PANCREAS RESECTION FOR ADENOCARCINOMA IN THE

ELDERLY PATIENTS; DOES AGE IMPACT THE OUTCOME?

Presenter: Alireza Hamidian Jahromi MD, MRCS | John C. McDonald

Regional Transplant Center

P 82. PANCREATICODUODENECTOMY WITH IRREVERSIBLE

ELECTROPORATION MARGIN ENHANCEMENT FOR BORDERLINE

RESECTABLE PANCREATIC CARCINOMA

Presenter: Amit Sastry MD | Carolinas HealthCare System

P 83. OUTCOMES OF PANCREATICODUODENECTOMY IN PATIENTS

WITH SUPERIOR MESENTERIC ARTERY CALCIFICATION

Presenter: Kelvin Wang BMBS, MRCS | St James’s University Hospital

P 85. PYOGENIC LIVER ABSCESS: EPIDEMIOLOGY, CLINICAL FEATURES

AND MANAGEMENT

Presenter: Helmut Alfredo Segovia Lohse MD | Hospital de Clínicas

P 86. CHOLECYSTECTOMY AFTER WALLED-OFF PANCREATIC

NECROSIS

Presenter: Joseph A Reza MD | Florida Hospital

P 87. STABILITY OF COUNTY RANKINGS IN LIVER TRANSPLANT

OUTCOMES

Presenter: Clifford Akateh MD | The Ohio State University and Nationwide

Children’s Hospital


AG E N DA



P 88. PANCREATIC CYSTGASTROSTOMY: DEFINITIVE OR

TEMPORIZING PROCEDURE?

Presenter: Edward Cho MD | Methodist Richardson Medical Center

P 89. CONGENITAL COMMON BILE DUCT AGENESIS: AN EXTREMELY

RARE ANOMALY. TWO CASE REPORTS AND REVIEW OF LITERATURE.

Presenter: Louis Chai MD | Drexel University College of Medicine


P 90. MAJOR HEPATECTOMY IN OCTOGENARIAN PATIENTS


P 91. HEPATIC ADENOMAS: PHENOTYPIC EXPRESSION, CASE

DESCRIPTION AND LITERATURE REVIEW.


P 92. POSTOPERATIVE COMPLICATIONS IN PATIENTS UNDERGOING

LAPAROSCOPIC CHOLECYSTECTOMY; VALIDATION OF THE RISK

CALCULATOR OF THE AMERICAN COLLEGE OF SURGEONS AT A

PRIVATE HOSPITAL IN MEXICO CITY.

Presenter: Victor José Visag-Castillo MD | Medica Sur Clinic Foundation

P 93. INCIDENCE OF SPLANCHNIC VEIN THROMBOSIS FOLLOWING

ABDOMINAL SURGERY, A SYSTEMATIC REVIEW AND META-

ANALYSIS.

Presenter: Minji Kim MD | McMaster University

P 94. WBC COUNT AS A SURROGATE OF SIRS IN THE EARLY

POST-OPERATIVE PERIOD. CAN IT PREDICT OUTCOMES AFTER

PANCREATICODUODENECTOMY?


P 95. MODIFIED HEIDELBERG TECHNIQUE FOR PANCREATIC

ANASTOMOSIS

Presenter: Orlando Torres MD, PhD | Federal University of Maranhao

P 96. LAPAROSCOPIC RESECTION OF SEGMENT IVB/V COLORECTAL

LIVER METASTASIS USING A NEW MULTIFUNCTIONAL ARTICULATING

VESSEL SEALER



AG E N DA



P 97. BARBED SUTURE FOR PANCREATIC ANASTOMOSIS DURING

PANCREATICODUODENECTOMY DECREASES INCIDENCE OF

CLINICALLY SIGNIFICANT PANCREATIC FISTULA

Presenter: Andrew Guzowski MD | Cleveland Clinic, Akron General

P 99. MINIMALLY INVASIVE PANCREATECTOMY FOR

ADENOCARCINOMA; A SINGLE CENTER EXPERIENCE WITH 100

RESECTIONS


P 101. THE PERSUIT OF SAFETY IN LAPAROSCOPIC HEPATECTOMY

Presenter: Naokazu Chiba MD, PhD | Tokyo Medical University Hachioji

Medical Center

P 102. PERCUTANEOUS CHOLECYSTOSTOMY FOR ACUTE CALCULOUS

CHOLECYSTITIS: OUTCOMES FROM A SINGLE CENTRE EXPERIENCE

Presenter: Francois Rouleau Fournier MD | CHU de Quebec - Laval University

P 103. TRANSVERSUS ABDOMINUS MUSCLE RELEASE WITH MESH

REINFORCEMENT IS SAFE AND EFFECTIVE FOR REPAIRING INCISIONAL

HERNIAS IN LIVER TRANSPLANT PATIENTS

Presenter: Dominic Sanford MD, MPHS | Washington University

P 104. PERCUTANEOUS TRANS-HEPATIC APPROACH TO ADDRESS

COMMON BILE DUCT STONE (CBDS) IN PATIENTS WHO HAD

LAPAROSCOPIC ROUX-EN-Y GASTRIC BYPASS (LRYGB)

Presenter: Gazi B. Zibari MD | John C. McDonald Regional Transplant Center

P 105. ROBOTIC-ASSISTED COMPLETION CHOLECYSTECTOMY

FOLLOWING PREVIOUS SUBTOTAL CHOLECYSTECTOMY -- A CASE

SERIES


P 106. POST-FELLOWSHIP COMMUNITY PRACTICE FACILITATES EARLY

ADOPTION OF ROBOTIC SURGERY AS ALGORITHM FOR APPROPRIATE

PATIENT SELECTION.

Presenter: Shanel Bhagwandin DO, MPH | Jupiter Medical Center

P 107. MANAGEMENT OF A DUODENOBRONCHIAL FISTULA AFTER

YTTRIUM 90 TRANSARTERIAL RADIOEMBOLIZATION IN A PATIENT

WITH RECURRENT HEPATOCELLULAR CARCINOMA

Presenter: Kliment Bozhilov MD | Johns Hopkins University School of

Medicine


AG E N DA



P 108. HEPATOCELLULAR CARCINOMA INVADING BILE DUCTS

PRESENTING AS A KLATSKIN TUMOR

Presenter: Jorge Uribe MD | Drexel University College of Medicine

P 109. DUCT PENETRATING METHOD (DPM) FOR

PANCREATOJEJUNOSTOMY WITH AN INTERNAL STENT PLACEMENT

BY “PUSH & PULL TECHNIQUE”

Presenter: Mio Nakatani MD | Kawasaki Medical School

P 110. PANCREATIC PSEUDOCYST DILEMMA; CUMULATIVE MULTI-

CENTERS EXPERIENCE IN MANAGEMENT USING ENDOSCOPY,

LAPAROSCOPY, AND OPEN SURGERY

Presenter: Mohammed Omar MD | South Valley University, Qena Faculty of

Medicine

P 111. VIDEO-ASSISTED RETROPERITONEAL DEBRIDEMENT IN A

PATIENT WITH INFECTED NECROTIZING PANCREATITIS

Presenter: Helmut Alfredo Segovia Lohse MD | Hospital de Clínicas

P 112. HSP70, GLUTAMINE SYNTHETASE, GLIPICAN3, PD1, PDL1 AND

BETACATENIN: IMMUNOHISTOCHEMICAL STUDY IN PATIENTS

UNDERGOING HEPATECTOMY FOR HEPATOCELLULAR CARCINOMA.

REVIEW OF RECURRENCE AND SURVIVAL.

Presenter: Simone Perales PhD | University of Campinas

P 113. MAJOR HEPATIC RESECTIONS IN A NEW HOSPITAL. HOW

AN EXPERIENCED SURGICAL GROUP CAN POSITIVELY AFFECT

OUTCOMES.


P 114. BENEFITS OF AN EIGHT-TEEN DAY PROGRAM ON CHRONIC

HEPATITIS

Presenter: Francisco Ramirez MD | Weimar Institute

P 115. LAPAROSCOPIC COMMON BILE DUCT EXPLORATION USING

FLUOROSCOPY GUIDED STONE BASKET EXTRACTION IN THE

MANAGEMENT OF EXTRAHEPATIC BILE DUCT STONES: A JOSE R.

REYES MEMORIAL MEDICAL CENTER EXPERIENCE

Presenter: Alain Neil Ancheta MD | Jose R. Reyes Memorial Medical Center

P 117. PANCREATODUODENECTOMY: BRAZILIAN PRACTICE PATTERNS

Presenter: Orlando Torres MD, PhD | Federal University of Maranhao


AG E N DA



P 118. PANCREAS TRANSECTION WITH LINEAR STAPLER AND BIPOLAR

CAUTERY FORCEPS IN DISTAL PANCREATECTOMY

Presenter: Toshimasa Okada MD, PhD | Kawasaki Medical School

P 119. COMPLEX DISTAL PANCREATECTOMY PERFORMED AT A

COMMUNITY CANCER CENTER

Presenter: Benjamin Gough DO | Helen F Graham Cancer Center & Research

Institute

P 121. RADIO-EMBOLIZATION WITH YTTRIUM-90 MICROSPHERES

FOR UNRESECTABLE INTRAHEPATIC CHOLANGIOCARCINOMA. WHO

GETS IT?


P 122. ROLE OF FAT AND FIBROSIS IN POST-OPERATIVE PANCREATIC

FISTULA

Presenter: Suman Bhushan Koganti MD | Nizams institute of medical

sciences

P 124. THE FIRST US REPORT OF MRI EOVIST AS A BILIARY AGENT. 2

CASE REPORTS.


P 125. URGENCY SURGICAL TREATMENT FOR RUPTURED HEPATIC

ADENOMA: EXPERIENCE OF 23 YEARS.


P 126. THE ROLE OF BILIARY T-TUBES IN CONTEMPORARY

HEPATOBILIARY AND EMERGENCY SURGERY: HAS THEIR TIME

PASSED?

Presenter: Sushant Chaudhary MD | University of Calgary

P 127. CENTRAL HEPATECTOMY FOR RARE PURE SQUAMOUS CELL

CARCINOMA OF THE GALLBLADDER WITH LOCAL EXTENSION INTO

LIVER

Presenter: Jayne McCauley MD | Texas Tech University Health Sciences

Center

P 128. EPIDEMIOLOGY OF PANCREATIC SOLID PSEUDOPAPILLARY

NEOPLASMS IN A CARIBBEAN POPULATION



AG E N DA



P 129. ACUTE LIVER FAILURE AS INITIAL PRESENTATION OF MULTIPLE

MYELOMA

Presenter: Amit Reddy MBBS | University of Mississippi Medical Center

P 130. HEPATIC ARTERY-PORTAL VEIN FISTULAS (APFS) FOLLOWING

A THORACO-ABDOMINAL STAB WOUND: CASE REPORT AND

LITERATURE REVIEW

Presenter: Amandeep Juneja MD | Staten Island University Hospital


P 131. A CASE SERIES OF CENTRAL HEPATECTOMY FOR

HEPATOCELLULAR CARCINOMA - A USEFUL PARENCHYMA

PRESERVING TECHNIQUE TO PREVENT POST-HEPATECTOMY LIVER

FAILURE.

Presenter: Phani krishna Ravula MS, MRCS, MCh | Pace Hospital

P 132. DOES COMPLIANCE WITH AN ERAS PROTOCOL FOR

PANCREATICODUODENECTOMY LEAD TO A DIFFUSION EFFECT ON

COMPLIANCE FOR LEFT PANCREATECTOMY?


P 133. MORBID THOUGHTS DECREASE ON INDIVIDUALS WITH

CONCUSSION HISTORY AFTER AN 8-WEEK EDUCATIONAL PROGRAM

Presenter: Francisco Ramirez MD | Nedley Clinic

P 135. PANCREATIC SURGERY IN OCTOGENARIAN PATIENTS


P 136. THE PANCREAS AS A TARGET FOR METASTASES OF

ABDOMINAL TUMORS

Presenter: Gabriel E. Gondolesi MD | Hospital Universitario Fundación

Favaloro (HUFF)

P 137. CASE SERIES TYPE 2 AUTOIMMUNE PANCREATITIS (OR IDCP):

AN AUSTRALIAN CASE SERIES AND ANALYSIS OF DIAGNOSTIC

APPROACH

Presenter: Krishna Pattabathula MBBS | Wesley Hospital

P 138. MANAGEMENT OF PATIENTS WITH ADENOCARCINOMA

Presenter: Sean Willis MS | Holy Cross Hospital


AG E N DA



P 139. FACTORS ASSOCIATED WITH BETTER SURVIVAL IN PATIENTS

UNDERGOING PANCREATICODUODENECTOMY FOR PANCREATIC

ADENOCARCINOMA


P 141. SURGICAL IMPORTANCE OF DUCT OF LUSCHKA ON BILE DUCT

LEAK : EMPIRICAL REVIEW OF LITERATURE.

Presenter: Natalia Cortes MD | Hospital Universitaria San Ignacio

P 142. IGG4-RELATED CHOLECYSTITIS PRESENTING AS MIRIZZI

SYNDROME.

Presenter: Nuria Ortega MD | Vall D’Hebron Universitary Hospital

P 143. SUPERIOR INTRAOPERATIVE PERFORMANCE OF HARMONIC HD

1000I SHEARS FOR PANCREATICODUODENECTOMIES


P 144. D4 OPENS A DOOR: ENDOSCOPIC ULTRASOUND GUIDED

TRANSDUODENAL DRAINAGE OF PERIPANCREATIC ABSCESS:A CASE

REPORT AND LITERATURE REVIEW.

Presenter: Essa Aleassa MD, MSc | Cleveland Clinic Foundation

P 145. SOCIODEMOGRAPHIC AND CLINICAL CHARACTERISTICS OF

PANCREATIC CYSTIC NEOPLASMS IN A REFERRAL CENTRE ON HPB IN

COLOMBIA.

Presenter: Camilo Ramirez MD | Mederi Hospital

P 146. TRAUMATIC HEMOBILIA

Presenter: Timothy Sahawneh MD | East Tennessee State University

P 147. IRREVERSIBLE ELECTROPORATION FOR POST-

PANCREATICODUODENECTOMY LOCALLY RECURRENT PANCREATIC

ADENOCARCINOMA: A CASE PRESENTATION

Presenter: Kiara Tulla MD | University of Illinois at Chicago

P 148. PANCREATIC NEUROENDOCRINE TUMOR: A DIAGNOSTIC

CHALLENGE IN FINE NEEDLE ASPIRATION CYTOLOGY


P 149. HILAR BILE DUCT NEUROENDOCRINE TUMOR: AN INCIDENTAL

FINDING



AG E N DA



P 150. DOUBLE CYSTIC MUCINOUS CYSTIC NEOPLASM AT THE BODY

AND THE TAIL OF THE PANCREAS.

Presenter: Natalia Lozano MD | Mederi Hospital

P 151. NEUROENDOCRIN TUMOR DE PANCREAS. PRESENTACION DE

AMPULOMAS CON HISTOLOGIA POCO FRECUENTE.

Presenter: Alejandro Fabian Rabellino MD | Hospital J. B. Iturraspe

P 152. EVERY OTHER DAY TREATMENT MAY REDUCE FATIGUE

IN HEPATOCELLULAR CARCINOMA PATIENTS TREATED WITH

STEREOTACTIC BODY RADIOTHERAPY

Presenter: Shaakir Hasan DO | Allegheny Health Network

P 153. IMPROVED PREDICTION OF HEPATIC FAILURE WITH THE

ALBUMIN-BILIRUBIN MODEL FOR HEPATOCELLULAR CARCINOMA

PATIENTS FOLLOWING STEREOTACTIC BODY RADIOTHERAPY WITH

AND WITHOUT TRANSPLANT

Presenter: Shaakir Hasan DO | Allegheny Health Network

HPB Fellowship Program ePosters


AG E N DA


ahpba 2018 finalprogram press 1 · ahpba 2018 annual meeting 47 wednesday, march 7, 2018 12:45pm -...

Documents